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ABSTRACT
MECHANISM OF ACTIVATION OF PHOTORECEPTOR PHOSPHODIESTERASE
BY TRANSDUCIN AND BY LOW MOLECULAR WEIGHT PROTEINS
by
Angela W. Norton
University o f New Hampshire, May, 2002

Rod photoreceptor phosphodiesterase (PDE) is the central enzyme o f visual
transduction. PDE is a heterodimer (Pa(3) with two associated inhibitory y subunits, and
is bound to the disk membrane by isoprenyl groups. Each catalytic subunit contains a
catalytic site and a high-affinity cGMP binding site. In this research, two independent
mechanisms o f PDE regulation are addressed. The first part examines transducin
activation of PDE, focusing on the interactions between the y subunits and Pa(3. The
second part examines the 17 kDa 5 protein believed to regulate bovine PDE. We found
that transducin activation o f PDE induces heterogeneity at the active sites as well as the
cGMP binding sites, and that there is a strong correlation between cGMP binding and y
binding to PDE. The PDE activition induced by transducin is approximately half of the
maximum rate o f P aP lacking bound y inhibitory subunits. This research supports a
model in which transducin interacts with y bound to only one o f the catalytic subunits.
The relationship between cGMP and y binding to PDE may play a role in light adaptation
o f rod photoreceptor cells.

x
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The 8 protein is hypothesized to regulate adaptation o f rod photoreceptor cells by
5 binding to the prenyl groups on PDE and releasing PDE from the disk membrane and
thereby preventing activation by transducin. The frog homologue o f the bovine 17 kDa 5
protein was identified in frog retina, but the amount of the 8 in rod cells was low (0.03 ±
0.01 mol 8 per mol PDE). This is consistent with frog PDE being >95% membraneassociated. Recombinant frog 8 bound to PDE and was able to release PDE from the
membrane. The majority o f the 8 in frog ROS is soluble, and the remainder does not copurify with PDE when extracted from the membranes. Immunocytochemical evidence
indicates that 8 localizes to the cone cells. W e hypothesize that 8 may serve to direct the
intracellular membrane trafficking for various prenylated proteins.

xi
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CHAPTER 1

INTRODUCTION
1. Retinal Diseases
Importance of vision research
A complete understanding o f visual transduction is necessary to fight retinal
diseases. Retinitis pigmentosa is the name given to a group of inherited retinopathies.
Approximately 1 in 3500 people suffer from retinitis pigmentosa. The retina is the tissue
at the back o f the eye that includes the rod and cone photoreceptor cells. Rod
photoreceptor cells are distributed across the retina. Cone photoreceptor cells are mostly
located in the central region o f the eye termed the macula. The majority o f people with
retinitis pigmentosa suffer from degeneration o f their rod cells. This results in nightblindness as well as the loss o f peripheral vision. As the disease progresses, cone cells
are also affected, often leading to complete blindness (Phelan and Bok, 2000). It has
been difficult to determine the exact cause o f retinitis pigmentosa since several different
factors can lead to the same symptoms. However, recent studies suggest that it is a
genetic disease, but that environmental factors can influence the rate o f progression of
retinal degeneration.
Another common photoreceptor cell disease is macular degeneration. This is the
degeneration o f the macula, affecting mainly the cone cells. People suffering from
macular degeneration gradually lose vision directly in front o f them and loss o f visual
acuity occurs as the cone photoreceptors degenerate (Fong, 2000). For elderly
1
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Americans, age-related macular degeneration is the m ajor cause o f non-treatable
vision loss. The exact cause o f age-related macular degeneration is still unknown. Loss
of vision completely alters a persons lifestyle, prohibiting activities many people take for
granted. For the elderly, the risk o f losing independence and the inability to perform
simple daily tasks is a severe concern. To combat the degeneration o f photoreceptor cells
seen in clinical studies, research must be done to understand the visual process. Once the
mechanism o f visual transduction in a healthy system is elucidated, the diseased state can
be compared to see what occurred to cause the degeneration. This will allow the
development o f drugs to treat the specific problem that led to the loss o f sight.

2. Visual Transduction
Visual excitation
Vertebrate photoreceptor cells are highly specialized neurons developed for visual
transduction. There are two different types o f photoreceptor cells: cones are for color
detection and daylight vision, while rods are for vision in low levels o f light. Although
rod and cone photoreceptor cells have different roles, the cells are similar in their basic
cellular function. Both consist o f an inner segment containing the vegetative cellular
machinery (nucleus, mitochondria, etc.) and an outer segment composed o f an extensive
membrane system. The large surface area o f the outer segment membranes is the site for
the protein components for the initial steps in vision. Though cellular morphology o f
rods and cones differs somewhat between the species, the central components of visual
transduction are well conserved throughout the vertebrates. There are three main stages
o f the visual process: excitation, termination and adaptation.

2
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Much is known about the excitation process o f visual transduction, as it is the
most well-studied o f the G-protein coupled receptor pathways. A photon o f light enters
the cell and is absorbed by a chromophore located in the central region o f the
transmembrane receptor, rhodopsin (Figure 1.1). Upon light absorption, the
chromophore, 11-cis retinal, undergoes a conformational change to all-trans retinal. This
activates the receptor and catalyzes the exchange o f GTP for GDP on the G-protein,
D a rk - ...... ► Light

GTP

Figure 1.1. Excitation pathw ay fo r vision. The initial components for visual
transduction are bound to the disk membranes o f the outer segment o f the cell. Light
photoactivates rhodopsin, catalyzing the exchange o f GTP for GDP on T a. T a
dissociates and binds to PDE, leading to a drop in cGMP concentration in the cell. The
cGMP-gated channels close and calcium levels drop, sending the light signal to the brain.

3
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transducin. G-proteins are named for their high affinity interactions with guanine
nucleotides and serve to transduce signals in many biochemical pathways. Transducin is
composed o f an a , P, and y subunit, with the GTP binding site on the a subunit
(Arshavsky et al., 2002). The a-subunit o f transducin with bound GTP (Ta-GTP)
dissociates from the transducin py subunits, then binds to and activates the effector
enzyme, phosphodiesterase (PDE). PDE hydrolyzes guanosine 3’, 5’monophosphate (cGMP) to guanosine 5’-monophosphate (GMP), causing the total
concentration o f cGMP in the outer segment to drop. In response to the drop in cGMP,
the cGMP bound to the cGMP-gated ion channels dissociates and the channels close
(Mendez et al., 2001; Pugh, Jr. and Lamb, 2000).
The cGMP-gated ion channels allow for a steady influx o f Na+ and Ca2+ into the
outer segment o f the photoreceptor cell. When photoreceptor cells are not exposed to
light, there is a circulating current with Na+ and Ca2+entering the outer segment o f the
cell through the cGMP-gated channel and exiting from the inner segment via a Na+/K+ATPase pump. W hen the cGMP-gated channel closes due to fight exposure, Ca2+, Na+,
and small amounts o f Mg2+ are no longer able to enter the cell, but Ca2+ is still pumped
out o f the cell by the exchanger (Pugh, Jr. and Lamb, 2000). The decrease o f positive ion
influx into the cell causes the membrane potential to become more negative. This causes
the cell to become hyperpolarized, transmitting the signal o f fight exposure to the
synaptic terminal o f the photoreceptor cell which communicates to many other classes o f
retinal neurons before passing to the optic nerve.
Rod photoreceptor cells are capable o f detecting a single photon o f fight. This
ability arises by two amplification steps that are intrinsically built into the visual

4
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transduction pathway. The first amplification step occurs upon activation o f rhodopsin.
Once activated, rhodopsin catalyzes the activation o f transducin and the G-protein is
released, but rhodopsin remains active. Thus, a single activated rhodopsin can continue
to activate —100 transducin molecules until rhodopsin itself becom es deactivated. The
second amplification step is the activation o f PDE. A single T a-G T P binds to PDE,
allowing the hydrolysis o f as many cGMP molecules as the enzyme encounters before T a
is deactivated and dissociates (Pugh, Jr. and Lamb, 2000; M endez et al., 2001; Arshavsky
et al., 2002). The amplification o f the signal at these two steps allows for a very small
stimulus to be reliably amplified and converted into a detectable signal to the nervous
system.

Termination o f the visual pathway
As with m any specialized pathways, termination o f the activated signal o f visual
transduction is not merely the reverse of the activation mechanism. To turn off visual
excitation, each o f the two amplification steps must be separately blocked. The
mechanism o f deactivation o f rhodopsin is very well known (Figure 1.2). The decrease
in intracellular calcium levels upon light activation stimulates a Ca2+ feedback
mechanism. Recoverin, a neuron-specific Ca2+-binding protein with two bound Ca2+,
exists associated to rhodopsin kinase bound in the dark state. Light exposure greatly
decreases the Ca2+ concentration, and the two Ca2+ bound to recoverin dissociate and
release rhodopsin kinase from recoverin. Rhodopsin kinase is then available to
phosphorylate distinct serine residues on rhodopsin. Phosphorylation o f rhodopsin
produces a binding site for arrestin, a 48 kDa protein that physically blocks the G-protein

5
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activation site on rhodopsin to ensure transducin can no longer be activated (Pugh, Jr. and
Lamb, 2000).

Light

Figure 1.2. Deactivation o f rhodopsin. The decrease in calcium levels induced by light
exposure releases rhodopsin kinase from its association with recoverin. Rhodopsin
kinase then phosphorylates distinct residues on the C-terminus o f rhodopsin. Once the
phosphorylation has taken place, arrestin will bind to rhodopsin, blocking the binding site
o f transducin and prohibiting further activation of the pathway.
After rhodopsin is deactivated, the chromophore dissociates from its ligand binding site
on the rhodopsin receptor and is reduced to all-trans retinol. In this state, the pigment
binds to an interphotoreceptor matrix retinoid binding protein (IRBP) which transports it
to the retinal pigment epithelium. It can then be converted to 11-cis retinal and returned
to the outer segment o f the photoreceptors bound to IRBP to complete the cycle of
pigment regeneration.
PDE activity must also be inhibited for termination o f the visual response. PDE
remains activated until hydrolysis o f GTP to GDP on T a occurs, allowing Ta-GDP to
dissociate and rebind to T(3y. Recently it has been shown that GTPase activating proteins
(GAP) work together to regulate the kinetics o f transducin deactivation. To enhance
hydrolysis o f GTP, Regulator o f G-protein Signaling 9 (RGS9) exists in a complex with
type 5 G-protein P subunit (GP5L) and increases the intrinsic GTPase activity of
6

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

transducin (He et al., 1998). GAP proteins work by stabilizing the transition state o f the
G-protein (in this case T a) to favor GTP hydrolysis (Arshavsky et al., 2002).
Deactivation of T a allows for the y subunit to return to its tight association with PDE,
blocking the catalytic site o f the enzyme. In vitro studies have shown that y released
from Pa(3 further enhances the GTPase activity o f transducin with RGS9 and G05L
(Arshavsky and Bownds, 1992; He et al., 1998; Makino et al., 1999).
The final step to recovering the dark-adapted state o f the cell is the production o f
cGMP. cGMP is formed by photoreceptor guanylate cyclase. In the dark, guanylate
cyclase binds guanylate cyclase activating proteins (GCAPS). These are calcium binding
proteins, that dissociate from guanylate cyclase when light activation decreases the Ca2+
in the cell. The release o f the GCAPS from guanylate cyclase stimulates the production
o f cGMP, leading to recovery o f the membrane potential.

Photoreceptor cell adaptation
The final stage o f the visual process is adaptation. Adaptation is the term used to
describe how photoreceptor cells adjust their photoresponse based on the previous history
o f light exposure. When photoreceptor cells have been in the dark long enough for the
transduction pathway to be completely turned off and the dark current restored, the darkadapted state is reached. There are two types o f light adaptation, background adaptation
and bleaching adaptation. The photoreceptor cells m ust be able to recognize a change in
light intensity when a background light exists, this is called light (or background)
adaptation. Part o f the adaptation mechanism is achieved by the two different types o f
photoreceptor cells. Rod photoreceptor cells are for the detection o f very low levels of

7
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light, down to a single photon. During the daytime, rod cells are completely saturated
with light. Bleaching adaptation is a continuous activation o f the pathway that is
believed to be due to the presence o f bleached pigment.
Background adaptation is composed o f two phases; a rapid phase lasting only a
few seconds, and a slow phase that occurs after tens o f seconds of light exposure. The
rapid phase o f light adaptation is stimulated by the low Ca2+ levels in the outer segment
arising from the closure o f the cGMP-gated ion channels. This decrease in the Ca2+
levels stimulates guanylate cyclase-activating proteins, causing guanylate cyclase to
produce cGMP which combats the drop in cGMP concentration due to PDE catalytic
activity. Simultaneously, the low Ca2+ levels increase the affinity o f cGMP for the
cGMP-gated ion channels permitting them to open at lower cGMP concentrations. While
the rapid phase o f light adaptation occurs at all light intensities, the slow phase is
observed only when the light intensity suppresses greater than 50% o f the dark current.
The actual cause o f the slow phase o f background adaptation is unknown, and the
continued drop in Ca

could mean that this effect is also mediated by the overall Ca

m

the outer segment o f the photoreceptor cell, but not necessarily (Calvert et al., 2002;
Bums and Baylor, 2001).
Bleaching adaptation is the ability o f the rod photoreceptor cells to adjust to
daytime saturation and recover for night vision. Rod photoreceptor cells exposed to
bright light become desensitized, preventing them from further stimulation by light. It is
well known that in order to recover from a bright flash o f light, the cell must regenerate
the visual pigment. However, throughout the time o f the pigment regeneration, the cell
behaves as though it is being continuously exposed to light, as the PDE remains active

8
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and cGMP levels are low. The cause o f this decrease in sensitivity is now believed to be
due to the presence o f bleached pigment in the cell. Rhodopsin is a protein containing a
covalently bound chromophore, 11-cis-retinal. D ining the visual cycle o f pigment
regeneration, the light-activated all-trans-retinol m ust dissociate and be exported to the
retinal pigment epithelium. Recent work suggests that the free opsin molecule (bleached
pigment) is able to directly activate transducin, causing desensitization by maintaining
the activated pathway (Melia, Jr. et al., 1997). The recovery o f the sensitivity o f the
pathway occurs with the regeneration o f the 11 -cis-retinal, allowing dark adaptation, and
the pathway is terminated until the next flash o f light (Fain et al., 2001).

3.

Structure and Regulation of Photoreceptor Phosphodiesterase

Structure and Function o f PDE
Due to its central role in the visual transduction pathway, PDE has been a major
focus o f research. There are eleven different members o f the PDE superfamily that have
been discovered thus far. All members of the PDE superfamily share sequence similarity
in the region corresponding to the active site o f the enzyme (SMART domain ID: HDc).
The photoreceptor cell PDEs (both rod and cone) discussed here are designated as PDE6.
Rod PDE is a heterodimeric protein composed o f a and p catalytic subunits (PaP). The
catalytic subunits are tightly associated with inhibitory y subunits (Figure 1.3). PDE6

9
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Figure 1.3. S tru ctu re of ro d photoreceptor PDE. PDE is composed o f two catalytic
subunits, PaP; and two identical inhibitory subunits, y. P a and Pp each contain a
catalytic site for cGMP hydrolysis, as well as an N-terminal GAF domain that binds
cGMP. PDE is attached to the membrane with isoprenyl groups. In mammalian ROS,
30% o f the PDE exists in a soluble form bound with a bound 8 subunit.
subunits contain a C-terminal catalytic domain as well as a tandem pair o f N-terminal
GAF domains encoding for cGMP binding sites (Artemyev et al., 1998). PDE2, PDE5,
PDE 10 and PDE11 are members o f the PDE superfamily that also contain GAF domains.
PDE2 demonstrates cooperative behavior, such that cGMP binding at the noncatalytic
sites stimulates cGMP hydrolysis at the catalytic site. Alternately, PDE5 shows allosteric
regulation, where the cGMP binding sites control the accessibility o f a phosphorylation
site responsible for regulating the catalytic site (Martins et al., 1982; Yamamoto et al.,
1983; Corbin et al., 2000). The exact role o f the GAF domains on PDE10 and PDE11 are
not well known.
Due to its importance in vision, research has focused largely on understanding
how PDE6 is regulated. One mechanism of direct regulation that could occur is
cooperation between the active sites and the noncatalytic cGMP binding sites as seen in

10
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PDE2. However, up to this point no evidence has been found to show any direct control
o f photoreceptor PDE activity from cGMP binding to the noncatalytic sites (Arshavsky et
al., 1992; Mou and Cote, 2001).
The C-terminal region of each of the catalytic subunits contains the consensus
sequence (CaaX) for post translational modification by protein prenyltransferases. The a subunit is famesylated and the (3 subunit is geranylgeranylated on the cysteine residue o f
the consensus sequence. Exposure o f PDE6 to limited trypsin proteolysis cleaves o ff a
portion o f the C-terminus o f the catalytic subunits, releasing them from their membraneassociated state. This suggests that prenylation o f the catalytic dimer is necessary for
membrane binding (Ong et al., 1989; Catty and Deterre, 1991), a mechanism that is often
used in signal transduction pathways. In vision, the coupling o f PDE6 to the membrane
ensures that the PDE is localized near transducin and can be quickly activated by light
exposure. In mammalian ROS up to 30% of the PDE is soluble with a bound 5 protein
(Gillespie et al., 1989). It is believed that 5 may play a role in adaptation by uncoupling
PDE from transducin activation (see below).
In a dark-adapted photoreceptor cell, PDE6 exists with two tightly associated y
subunits (Cote, 2000). y binds to the catalytic dimer with very high affinity (Kd<10 pM)
(Wensel and Stryer, 1986) and inhibits cGMP hydrolysis by physically blocking the
active site (Takemoto et al., 1993; Artemyev et al., 1998). The high affinity interaction
ofy is through the central region o f the protein (residues 24-45) whereas the C-terminal
region o f the protein inhibits cGMP hydrolysis (Mou and Cote, 2001).
There are many fewer cone cells than rod cells in the majority o f vertebrate
retinas. Thus, less is known about cone PDE because it is difficult to obtain purified

11
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biochemical amounts o f the enzyme to study. Sequence analysis shows that cone PDE
exists as a homodimer o f a ’ subunits. Each o f these catalytic subunits contains an active
site for cGMP hydrolysis and at least one noncatalytic cGMP binding site. Similar to rod
PDE, the catalytic activity of cone PDE is regulated by the binding o f two inhibitory y’
subunits. There is still a lot o f work that needs to be done to characterize cone PDE and
understand how it is regulated in vivo.

v release from PaB upon transducin activation
There is some debate as to the interactions o f the PDE subunits upon transducin
activation o f PDE. In bovine PDE, y has such a high affinity for one o f the catalytic
subunits that cGMP is not readily exchanged from one o f the noncatalytic binding sites.
However, frog PDE contains two exchangeable cGMP binding sites at all times. It is
well known that there is a highly cooperative relationship between occupation o f the
cGMP binding sites and y binding affinity. Experimental manipulations can remove most
y from its association with P ap when PDE is activated by Ta-GTP in the absence o f
cGMP. It remains to be seen whether cGMP levels in the outer segment drop low enough
to allow y to be released from P ap during the visual process. The specifics o f y release
from P a p occurring in vivo are further examined in this thesis. If y is released in vivo, it
could serve an important function, since free y binds to RGS9 to stimulate GTP
hydrolysis on transducin, thereby causing T a-G D P to dissociate from y leading to
termination o f visual transduction (Arshavsky and Bownds, 1992; Calvert et al., 1998;
Makino et al., 1999). Thus, one could envision the dissociation o f y being involved in
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light or bleaching adaptation, by reducing cGMP hydrolysis and thus reducing
expenditure o f metabolic energy.

Regulation of PDE6 by phosphorylation
One line o f current research is looking at whether phosphorylation o f the y subunit
o f PDE serves to regulate PDE. When y is free from association with Pap, it can also
serve as a substrate for phosphorylation in vitro. Previous research suggested that when y
is phosphorylated, it inhibits PDE catalysis stronger than the unphosphorylated form (Xu
et al., 1998; Tsuboi et al., 1994; Hayashi et al., 2000; Udovichenko et al., 1994).
However, more recent results contradict this finding. Instead, they propose that once
phosphorylation o f y occurs, it is no longer capable o f binding to Ta-GTP. Thus, the
phosphorylated y will reassociate with P a p without binding to any alternative Ta-GTP
molecules that may be present, thus speeding up the recovery phase o f the pathway
(Paglia et al., 2002). This would be important, as the stoichiometry o f T a to PDE is 12 to
one, respectively in ROS (Arshavsky et al., 2002). Another hypothesis is that
phosphorylation o f y actually serves to regulate an alternate pathway located in the rod
outer segment. If y does indeed get released from PDE due a large decrease in the cGMP
concentration, it would then make an excellent substrate for phosphorylation. Since this
soluble, phosphorylated y cannot bind to T a, it would be available for interacting with
proteins from another signal transduction pathway. However, at this point it is still
unclear as to whether or not significant levels o f y phosphorylation occur in vivo.
The phosphorylation o f PaP is also being examined as a mechanism o f enzyme
regulation, but the importance o f this has not yet been completed. PDE5 has been shown

13

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

to be regulated by phosphorylation o f its catalytic subunits such that when cGMP is
bound to the noncatalytic sites, PDE5 is more likely to be phosphorylated (Corbin et al.,
2000). The likelihood o f PDE6 being phosphorylated in vivo and the effect o f this
phosphorylation are currently being examined.

A 17 kDa 8 protein is a putative subunit of PDE6
PDE is likely to be regulated by other proteins located in the outer segment. In
bovine ROS, a 17 kDa 5 subunit solubilizes PDE from the membrane such that -30% of
bovine rod PDE exists off in the cytosol (Gillespie et al., 1989; Florio et al., 1996). This
5 protein is conserved among mammals showing a 96% sequence identity. Similar
proteins have also been found in amphibians (80% identity) as well as C. elegans (70%
identity) and D. melanogaster (60% identity) (Florio et al., 1996; Li and Baehr, 1998; Li
et al., 1998; Lorenz et al., 1998; Adams et al., 2000). The proposed role of 5 is to
regulate PDE by removing it from the rod disk membranes and away from membranebound association with transducin (Figure 1.4) (Cook et al., 2001).

Light activation

P rolonged light
activation

Figure 1.4. Proposed role o f the 8 protein. Upon light exposure, Ta-GTP
dissociates from T(3y, and binds to PDE causing activation. When light activation is
prolonged, 8 binds to PDE at the C-terminus and releases it from the membrane, leaving
Ta-GTP bound by its myristoyl group to the disk membrane.
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The interaction between PDE and 8 is believed to occur at the C-terminus o f the
catalytic subunits, and to involve the isoprenyl groups which attach PDE to the
membrane. Trypsinized PDE, lacking the C-terminus o f the catalytic subunits, does not
bind to 5. In addition, release o f PDE from the disk membranes can be blocked by
peptides containing a small sequence from the PDE C-terminus. PDE solubilized by 5
contains a higher level o f carboxymethylation than the PDE that remains membranebound (Cook et al., 2000).
Besides altering membrane association, 8 also regulates PDE by altering cGMP
binding to the noncatalytic sites (Mou et al., 1999). In bovine PDE, the interaction o f the
y subunit with one o f the catalytic subunits is so tight that the cGMP is not released.
Addition o f 8 to this membrane-associated PDE both releases the enzyme from the
membrane and allows cGMP to be exchanged from both o f the noncatalytic cGMP
binding sites. However, it is still unclear whether 8 plays a role in regulating PDE in
vivo.

Regulation of PDE by GAKP
Another protein believed to interact with PDE and decrease its catalytic activity is
GARP (glutamic acid-rich protein). Research suggests that GARP serves to prevent
cGMP hydrolysis when rod photoreceptor cells are completely saturated with light
(Korschen et al., 1999). GARP binds to PDE, and is hypothesized to compete with T aGTP thereby reversing transducin activation o f PDE. The interaction o f PDE with other
photoreceptor proteins is currently being examined. It is possible that there exists a
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signaling complex for proteins involved in visual transduction, similar to the inad
complex found in Drosophila. As there are many proteins in the outer segment o f rod
photoreceptor cells, it is likely that some proteins regulating visual transduction have not
yet been discovered.

4. Thesis research goals
Model for vision research
Due to the conservation o f rod photoreceptor proteins in the visual pathway, the
species used for research does not often matter. Most o f the work done to date used
bovine photoreceptor cells because they are available in large quantities from
slaughterhouses. The concern arises in that bovine retinas obtained from the
slaughterhouses are light-adapted, and the conditions o f retinal isolation are not under the
control o f the investigator. Thus, in order to make a more physiological assessment of
the visual transduction pathway, the common bullfrog (Rana catesbeiana), is often used.
The animals are easy to maintain in a controlled light environment, and all aspects of
retinal isolation and light exposure can be controlled. In this way, preparations o f darkadapted purified ROS can be isolated and used to compare the biochemical pathways of
the rod outer segment to the well characterized electrical responses o f the same cell
preparation.

Goal o f thesis research
This research focuses on the regulation o f rod PDE through cGMP, Py, T a or 5
binding. The first section o f the thesis examines a complete characterization o f frog
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PDE, observing catalytic rates as well as cGMP association, dissociation and equilibrium
binding to the noncatalytic sites. The correlation between cGMP binding to the
noncatalytic sites and y binding to PDE was studied in more detail as well. Each o f these
pieces combined to form a model describing transducin activation o f PDE in
physiologically competent frog ROS. The second section o f the thesis deals with the
regulation o f PDE by the 5 protein in frog ROS. The in vivo levels o f the 5 protein in
frog ROS was measured under several illumination conditions. For comparison to
previous studies in bovine ROS, the in vitro effect o f frog 5 on PDE was also measured.
Co-purification o f 6 and PDE was examined to test the possibility that delta or delta-like
proteins interact with PDE to regulate visual transduction. The final part o f this thesis
contains research that addresses PDE-binding proteins. Much o f this section focuses on
the y subunit o f PDE, but the existence o f other PDE-binding proteins is also explored.
These experiments were preliminary studies that evolved into projects studied by m yself
or other lab members. Some o f these observations may be used for future research in the
lab.
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CHAPTER 2

MECHANISM OF TRANSDUCIN ACTIVATION OF FROG ROD
PHOTORECEPTOR PHOSPHODIESTERASE: ALLOSTERIC
INTERACTIONS BETWEEN THE INHIBITORY y SUBUNIT AND
THE NONCATALYTIC cGMP BINDING SITES1

Summary
The rod photoreceptor phosphodiesterase (PDE)2 is unique among all known
vertebrate PDE families for several reasons: it is a catalytic heterodimer (aP ), it is
directly activated by a G-protein, transducin, and its active sites are regulated by
inhibitory y subunits. Rod PDE binds cGMP at two noncatalytic sites on the aP dimer but
their function is unclear. We show that transducin activation o f frog rod PDE introduces
functional heterogeneity to both the noncatalytic and catalytic sites. Upon PDE

1 This paper was published in the Journal o f Biological Chemistry: Norton, A. W.,
D'Amours, M. R., Grazio, H. J., Hebert, T. L., and Cote, R. H. (2000) J.Biol.Chem. 275,
38611-38619. This work was supported by National Institute o f Health Grant EY-05798
(to R. H. C.). This paper is scientific contribution 2058 from the New Hampshire
Agricultural Experiment Station.
2 The abbreviations used are: PDE, phosphodiesterase (EC 3.1.4.35); PDE6, retinal
photoreceptor PDE; P aP , catalytic heterodimer of PDE; Py, inhibitory 10 kDa y subunit
o f rod PDE; a t, a-subunit o f the rod photoreceptor G-protein, transducin; ROS, rod outer
segments; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis;
nPDE, nonactivated PDE; tPDE, trypsin-activated PDE; taPDE, transducin-activated
PDE; GTPyS, guanosine 5’-0-[3-thiotriphosphate], a t-GTPyS, activated form o f a t; kat,
turnover number for activated PDE (units: cGMP hydrolyzed per s) based on the PaP
dimer concentration; PDE1, calcium-calmodulin-dependent PDE.
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activation, one noncatalytic site is converted from a high affinity to low affinity state,
while the second binding site undergoes modest decreases in binding affinity. Addition o f
y to transducin-activated PDE can restore high affinity binding as well as reducing cGMP
exchange kinetics at both sites. A strong correlation exists between cGMP binding and y
binding to activated PDE: dissociation o f bound cGMP accompanies y dissociation from
PDE, while addition o f either cGMP or y to a p dimers can restore high affinity binding
o f the other molecule. At the active site, transducin can activate PDE to about one-half
the turnover number for catalytic a p dimers completely lacking bound y subunit. These
results suggest a mechanism in which transducin interacts primarily with one PDE
catalytic subunit, releasing its full catalytic activity as well as inducing rapid cGMP
dissociation from one noncatalytic site. The state o f occupancy o f the noncatalytic sites
on PDE determines whether y remains bound to activated PDE or dissociates from the
holoenzyme, and may be relevant to light adaptation in photoreceptor cells.

Introduction
Initiation o f the phototransduction cascade in vertebrate rod photoreceptors by
light results in the sequential activation o f the visual pigment (rhodopsin), the
photoreceptor G-protein (transducin), and the effector enzyme (cGMP phosphodiesterase,
PDE)[for reviews, see ref. (Stryer, 1991; Pugh, Jr. and Lamb, 1993; Helmreich and
Hofmann, 1996; Arshavsky and Pugh, Jr., 1998)]. The PDE present in rod and cone
photoreceptors (classified as PDE6) differs in several ways from other classes o f
mammalian phosphodiesterases (Loughney et al., 1996; Manganiello and Degerman,
1999; Soderling and Beavo, 2000): rod photoreceptor PDE forms a catalytic dimer from
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two closely related a and p subunits (PaP); rod and cone PDE are directly regulated via
heterotrimeric G-proteins; the catalytic constant (kcat) for rod PDE is ~1000-fold greater
than for any other class o f PDE; the catalytic activity o f photoreceptor PDE is potently
inhibited by binding o f an inhibitory y subunit (Py) [for reviews, see ref. (Takemoto et al.,
1993; Artemyev et al., 1998)].
Transducin activation o f PDE results from binding of the activated transducin a t
subunit ( a r GTP) to one or more sites on the PDE holoenzyme. One result o f this
interaction is the displacement o f the inhibitory Py subunit from its binding site in the
catalytic pocket o f PDE. It is not clear, however, whether each PDE catalytic subunit
binds Py with equal affinity, whether a t-GTP can activate each catalytic site equally well,
and under what conditions the a t-GTP-Py complex dissociates from PaP- Conflicting
results reported by different laboratories may reflect underlying differences in how the
phototransduction components were isolated and studied, as well as species differences in
the protein-protein interactions o f transducin and PDE (Yamazaki et al., 1983; Wensel
and Stryer, 1986; Bennett and Clerc, 1989; Bennett et al., 1989; Whalen and Bitensky,
1989; Yamazaki et al., 1990; Wensel and Stryer, 1990; Clerc and Bennett, 1992; Clerc et
al., 1992; Otto-Bruc et al., 1993; Bruckert et al., 1994; Dumke et al., 1994; D’Amours and
Cote, 1999; Berger et al., 1999; Melia et al., 2000).
Comparison o f the amino acid sequence o f photoreceptor PDE with PDE2, PDE5,
PDE 10 and PD E11 reveals the presence o f GAP domains (Aravind and Ponting, 1997) in
the N-terminal half o f each PDE that encode noncatalytic cGMP binding sites
(Charbonneau et al., 1990; McAilister-Lucas et al., 1993; Manganiello and Degerman,
1999; Soderling and Beavo, 2000; Fawcett et al., 2000; Yuasa et al., 2000). In the case o f
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PDE2, cGMP binding to these noncatalytic sites directly stimulates cyclic nucleotide
hydrolysis at the active site (Martins et al., 1982; Yamamoto et al., 1983). For PDE5, the
noncatalytic sites allosterically regulate accessibility o f a phosphorylation site that alters
catalytic activity (Bums et al., 1992; Turko et al., 1998; Corbin et al., 2000). The possible
regulatory function for the low affinity, noncatalytic sites on PDE 10 is not known, nor is
it known whether the GAF domains in PDE 11 represent functional cGMP binding sites.
Since the initial findings by Yamazaki et al. (Yamazaki et al., 1980; Yamazaki et
al., 1982) that cGMP bound with high affinity to rod photoreceptor PDE, several possible
roles for the noncatalytic sites on rod PDE have been proposed. One hypothesis is that
cGMP occupancy o f the noncatalytic sites on PDE affects the strength o f the interaction
between the inhibitory Py subunit and P a p [reviewed in ref. (Artemyev et al., 1998)]. It
has also been proposed that changes in cGMP binding affinity to the noncatalytic sites
during visual transduction might permit the release o f bound cGMP to accelerate the
restoration o f cGMP levels during the recovery phase o f the photoresponse (Cote and
Brunnock, 1993; Yamazaki et al., 1996a). Finally, the idea that the noncatalytic sites on
photoreceptor PDE might directly regulate hydrolysis o f cGMP at the active site (as is the
case for PDE2) has not been supported by current evidence (Arshavsky et al., 1992;
D'Amours and Cote, 1999).
In this paper, we characterize the properties o f non-activated, transducinactivated, and catalytic dimers o f PDE, all derived from suspensions o f purified
amphibian rod outer segments, in order to provide a detailed account o f the changes that
occur at the catalytic and noncatalytic domains o f PDE upon light activation o f the
phototransduction cascade. W e demonstrate a direct correlation between occupancy of
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cGMP at the noncatalytic sites o f PDE and the state o f association o f the inhibitory Py
subunit. Our results are consistent with transducin activation reducing cGMP binding
affinity primarily at one o f the two high-affinity, noncatalytic sites on PDE. Furthermore,
transducin activation o f PDE cannot achieve the maximum catalytic potential o f PDE that
is observed when the Py subunits are completely removed from the P a p catalytic dimer.
These changes in the noncatalytic and catalytic sites upon transducin activation are
mediated through changes in Py interaction with PaP upon binding o f transducin to PDE.
The coordinated, allosteric regulation o f cGMP and Py binding to P aP upon transducin
activation operate too slowly to play a role in the rapid events o f rod phototransduction
(i.e., excitation and recovery), but may be important in m ore slowly developing aspects
o f light adaptation.

Experimental Procedure
Materials. Frogs (Rana catesbeiana) were obtained from Niles Biologicals.
[3H]cGMP was from NEN Life Science Products. Membranes for filter binding assays
were obtained from Millipore. Reagents, substrates and nitrocellulose membranes for
immunoblotting were from Pierce Chemical Co. or from Bio-Rad. Silicone oils for
centrifugal separation were obtained from the William F. Nye Co. All other chemicals
were obtained from Sigma.

Preparation o f Frog Rod Outer Segments (ROS) and recombinant bovine rod
PDE inhibitory ysubunit (Py). Osmotically intact frog ROS were purified on a
discontinuous Percoll density gradient exactly as described in ref. (Cote, 2000). Purified
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ROS were homogenized in Buffer A [containing: 77 mM KC1, 35 mM NaCl, 2.0 mM
MgCI2, 1.0 mM CaCl2, 10 mM HEPES (pH 7.5), 2 mM dithiothreitol, 1 mM 4-(2aminoethyl)-benzenesulfonyl fluoride, 5 pM leupeptin, and 1 pg/ml pepstatin] following
the method o f Dumke et al. (Dumke et al., 1994). Homogenized ROS were incubated in
the dark at room temperature for 20-30 min to allow endogenous nucleotide hydrolases to
degrade cGMP and GTP levels prior to experimental manipulations. Following depletion
o f nucleotides and determination o f the rhodopsin concentration by difference
spectroscopy (Bownds et al., 1971), ROS samples were exposed to light for subsequent
steps (unless otherwise noted). The PDE concentration in ROS homogenates was
determined by its ability to bind a maximum o f 2 mol cGMP per mol holoenzyme in its
non-activated state when supplemented with stoichiometric amounts o f exogenous Py
(see (Cote, 2000) for details).
Subcellular fractionation o f ROS homogenates was typically performed by
centrifuging samples for 1-3 min at 30 psig (110,000 x gaV) at room temperature using a
Beckman Airfuge. We verified that the integral membrane protein, rhodopsin, was
present in the supernatant at undetectable levels and that >95% o f the total rhodopsin
could be recovered in the membrane pellet under these conditions.
Recombinant bovine rod Py was expressed in E. coli and purified to >97% purity
as described in ref. (Granovsky et al., 2000). The Py concentration was determined
spectrophotometrically using an experimentally determined extinction coefficient o f 7550
OD M '1 (Cote, 2000). The inhibitory activity o f purified Py was assayed by its ability to
stoichiometrically inhibit trypsin-activated bovine rod PDE (Mou et al., 1999); the
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spectrophotometric and activity estimates o f Py concentration agreed to within 10% for
all Py preparations used in this study.

PDE preparations used in this study. Since PDE6 is the only detectible isoform
o f phosphodiesterase in purified ROS, no additional purification o f the rod PDE was
required. Non-activated PDE (nPDE) was obtained directly from nucleotide-depleted
ROS homogenates; in the absence of GTP, dark-adapted and light-exposed ROS
homogenates show no difference in the rate o f cGMP hydrolysis or in the extent of
cGMP binding. The catalytic activity o f nPDE was typically 1-3% o f the activated rate at
the concentrations used in this paper (D'Amours and Cote, 1999). Transducin-activated
PDE (taPDE) was prepared by incubating nucleotide-depleted ROS homogenates ([PDE]
> 1 2 nM; see (Dumke et al., 1994)) with an excess o f GTPyS relative to the transducin
concentration [-30 transducins per PDE; (Hamm and Bownds, 1984)]. Trypsinized PDE
(tPDE), in which the Py subunits are proteolytically digested to relieve their inhibitory
constraint (Hurley and Stryer, 1982), was prepared by incubating ROS homogenates with
TPCK-treated trypsin, followed by addition o f a 6-fold molar excess of soybean trypsin
inhibitor. The time course and concentration dependence o f activation was closely
followed to determine the minimum exposure o f PDE to the pro tease yielding full
activation (see Results). Excessive proteolysis o f PDE leads to a gradual loss in the
maximal catalytic activity, as well as irreversible damage to the noncatalytic sites. We
prepared PDE heterodimers (Pap) depleted o f Py by modifying the original method o f
Yamazaki et al. (Yamazaki et al., 1990): nPDE was incubated with GTPyS for 60 min at
4° to allow Py to dissociate from Pap, and then centrifuged in the Airfuge to pellet ROS
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membranes. The supernatant was discarded and the ROS membrane treated with GTPyS
once more to further release membrane-bound Py. Following the second centrifugation,
ROS membranes retained all o f the original PaP content, but only 10-35% o f the original
Py (depending on the individual preparation). [The content o f a t in GTPyS-washed ROS
membranes was also reduced to <30% o f its concentration in ROS homogenates, as
judged by immunoblot analysis with anti-at antibodies.] P a p was used immediately
following its preparation, because the enzyme was unstable once most o f the Py had been
removed. Only preparations containing <25% o f the original Py content (i.e., < 0.5 Py per
PDE) were used in experiments employing Pap. Efforts to completely eliminate Py from
our P ap preparations were unsuccessful.

Binding o f cGMP to noncatalytic sites on PDE. Because PDE is the only rod
photoreceptor protein that binds cGMP with high affinity (Kd < |xM) (Cote and
Brunnock, 1993; Cote et al., 1994), we were able to measure changes in binding
occupancy at the noncatalytic sites of PDE in unfractionated ROS homogenates. For most
experiments, a cGMP filter binding assay (Cote, 2000) was used to quantify binding of
[3H]cGMP to high affinity sites on PDE. Inclusion o f zaprinast or E4021 (D1Amours et
al., 1999) with the [3H]cGMP solution during the filter binding assay prevented cGMP
breakdown during the incubation with nPDE or activated PDE. In some experiments, the
cGMP binding reaction was halted by addition o f ice-cold 95% saturated a m m onium
sulfate (Cote, 2000) prior to membrane filtration o f the quenched samples.
In order to directly correlate cGMP binding with Py binding to activated PDE
(shown in Figure 2.4), we employed a centrifugal separation assay through a silicone oil
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layer that partitions free [3H]cGMP from bound nucleotide (Forget et al., 1993; Cote,
2000). Portions (10 p.1) o f ROS homogenates were layered on top o f 100 pi o f silicone oil
(density, 1.020 g/ml) in a 5 x 20 mm centrifuge tube (Beckman) at 4°. The tubes were
spun at room temperature for 3 min at 110,000 x gaV. Supernatants remaining above the
oil layer were removed and processed for immunoblot analysis o f Py concentration. The
pellets were resuspended and one portion analyzed for Py content, while the other portion
was used to quantitate bound [3H]cGMP.

Quantitative immunoblot analysis o fP y concentration in ROS. Samples for Py
analysis were added to electrophoresis sample buffer, and then subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). After electrophoretic
transfer to a 0.45 pm nitrocellulose membrane, the presence o f Py was detected with an
affinity-purified rabbit polyclonal antibody (UNH9710-4P; 1:15,000 dilution) specific for
amino acid residues 63-87 o f bovine rod Py. [Frog (Rana pipiens) Py has an identical
amino acid sequence to bovine Py in this region; Wolfgang Baehr, personal
communication.] Binding o f the Py antibody was determined using a goat anti-rabbit
antibody coupled to horseradish peroxidase (1:4000 dilution), followed by incubation of
the membrane with substrate (SuperSignal West Pico Chemiluminescent Substrate,
Pierce) and luminescent detection on film (Kodak BioMax Light). The intensity o f the Py
immunoreactive bands was recorded using a scanner and analyzed using the image
analysis program, Quantiscan (Biosoft). The concentration o f Py in ROS samples was
calculated by comparison to a standard curve generated with known amounts (0.5 - 15
ng) o f recombinant Py on the same blot, as described in detail elsewhere (Cote, 2000).
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PDE activity assay. The rate o f cGMP hydrolysis catalyzed by non-activated and
activated forms o f PDE was measured by a coupled-enzyme phosphate release assay, as
described in detail in ref. (Cote, 2000). Activity measurements were made in the
following buffer: 100 mM Tris, 10 mM MgCl2 , 0.5 mM EDTA, 2 mM dithiothreitol, 0.5
mg/ml bovine serum albumin, pH 7.5. In all cases, rate measurements were obtained
from at least three individual time points at saturating cGMP concentrations (10 mM),
during which time less than 30% o f the substrate was consumed.

Other methods. SDS-PAGE was performed by the method o f Laemmli in 15%
acrylamide gels (Laemmli, 1970). The immunoblotting protocol closely followed
standard procedures (Gallagher, 1998). Fitting o f PDE activity data was carried out with
nonlinear regression analysis using Sigmaplot. Equilibrium binding data as well as the
kinetics o f cGMP association and dissociation were analyzed as described in ref. (Cote,
2000); in all cases, statistical comparisons o f one-site versus two-site fits were carried out
using KELL (Biosoft) to determine whether PDE exhibited one or two distinct classes o f
cGMP binding sites.

Results and Discussion
Transducin activation o f PDE converts one class o f noncatalytic sites to a low
affinity, rapidly exchanging state. While it has been reported that transducin activation o f
photoreceptor PDE leads to changes in cGMP binding to the noncatalytic sites o f the
enzyme, the regulatory and physiological significance o f this process is not well
understood. A previous study reported that transducin activation o f PDE accelerated
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cGMP exchange and reduced the binding affinity o f cGMP to the noncatalytic sites on
the enzyme without a significant reduction in the stoichiometry o f binding (Cote et al.,
1994). However, this work was conducted with PDE preparations supplemented with
exogenous Py subunit that markedly affects the interaction o f cGMP with the noncatalytic
sites (see below). Therefore, we chose to examine the cGMP binding properties o f
nonactivated and transducin-activated PDE in ROS homogenates containing only the
endogenous Py that is present in rod photoreceptor cells. We carried out equilibrium and
kinetic studies at 4° to slow the binding reactions for accurate measurements o f the rate
constants.
Non-activated, nucleotide-depleted PDE (nPDE) in frog ROS homogenates binds
cGMP with high affinity and as a single class o f noninteracting binding sites at 4° (K d —
8.4 nM, Bjnax = 1 .7 mol cGMP per mol PDE ; see Table 2.1). The measured K d for cGMP
binding to frog nPDE agrees with previous estimates when the temperature dependence
o f the binding reaction is accounted for (Cote and Brunnock, 1993). [The Bmax o f nPDE
can be increased to 2.0 by addition o f < 1 Py per PDE (see Figure 2.2C), suggesting that a
small amount o f Py was lost during preparation o f nPDE.] When transducin is activated
by addition o f GTPyS to illuminated ROS homogenates and then 10 - 400 nM [3H]cGMP
is added, transducin-activated PDE (taPDE) undergoes a 7-fold decrease in binding
affinity (K d = 57 nM) and a substantial loss in the number o f cGMP binding sites (Bmax =
1.0 mol cGMP per mol PDE; Table 2.1). At higher [3H]cGMP concentrations up to 1.3
pM, we detected an additional 0.3 mol cGMP bound per PDE, but could not
resolve a distinct, second class o f binding sites. To improve detection o f low affinity
cGMP binding sites, we prepared high specific activity [32P]cGMP, and found that
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Table 2.1
Equilibrium and Kinetic Parameters for High Affinity cGMP Binding to Frog PDE*

nPDE
taPDE

K d (obs.)b

k-i°

k+id

(nM)

(sec'1)

(M^sec"1)

8.4 ± 1.8 (5)
slow:
fast:

3.4 ± 0.2 x 10"4 (7)

7.6 ± 0.8 x 104 (6)

3.4 ± 1.2 x 1C4; 64% (8)
57 + 9.4 (8)

7.8 + 0.8 x 104 (7)
2.9 ± 0.9 x 10'3; 36% (8)

a Binding o f [3H]cGMP to non-activated PDE (nPDE) and transducin-activated PDE
(taPDE) were performed at 4° as described in the Experimental Procedures. ROS
homogenates were depleted o f nucleoside phosphates prior to use. Values represent the
mean ± S.E.M for the number o f determinations shown in parentheses.
b Equilibrium binding measurements of cGMP to nPDE were performed at 4° by mixing
PDE (8-11 nM) with 1 - 400 nM [3H]cGMP and incubating for 30 min. Transducinactivated PDE (8-17 nM) was pre-incubated with GTPyS (added at a concentration equal
to the rhodopsin concentration) for 1 min prior to addition o f [3H]cGMP. The Bmax
obtained from these binding isotherms was 1.73 ± 0.11 and 0.98 ± 0.11 mol cGMP per
mol PDE for nPDE and taPDE, respectively. A second class o f low affinity sites on
taPDE was not detected in these experiments (see text).
c Dissociation rate constants (k-i) were determined as described in Fig. 1. Percentage
values represent the proportion o f the total binding sites exhibiting rapid or slow cGMP
dissociation with taPDE in a two-site fit o f the dissociation kinetics.
dAssociation rate constants (k+i) were calculated from the kobs values in Fig. 1 using the
equation: k+i = (kobs - k.i)/[cGMP], where [cGMP] is the total cGMP concentration and
ligand depletion is not significant (Hulme and Birdsall, 1992).

increasing the [32P]cGMP concentration from 1 p.M to 15 pM results in a progressive
(K 1/2 ~ 5 pM) increase in total cGMP binding to taPDE from 1.2 to 1.9 cGMP bound per
PDE (data not shown). Low affinity cGMP binding sites were not detected with nPDE.
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Thus, activation o f PDE by transducin induces heterogeneity in the noncatalytic sites on
PDE, with a large decrease in binding affinity at one noncatalytic site, and a more modest
change at the second site.
Measurements o f the rate o f cGMP association and dissociation were performed
to better understand how transducin activation differentially affects cGMP binding to the
two noncatalytic sites o f PDE. When PDE is incubated with 1 pM [3H]cGMP, a single
class o f cGMP binding sites is resolved (Figure 2.1 A), and the association rate constant is
identical for nPDE and taPDE (Table 2.1). [The low affinity cGMP binding sites on
taPDE (-0.2 cGMP per PDE under these conditions) apparently did not contribute
sufficiently to be resolved in Figure 2.1 A.] Thus, transducin activation does not
significantly alter the initial step o f cGMP binding to the moderate affinity class of sites
on taPDE. The association rate constant for cGMP binding (k+i = 8 x l0 4 M 'V ) is
approximately 3 orders o f magnitude below the diffusion-controlled limit for a simple
bimolecular protein-ligand binding reaction (Gutfreund, 1995). Restricted diffusion o f
cGMP to the binding pocket o f the noncatalytic sites may result from binding o f Py in
proximity to the noncatalytic domains on P ap (Natochin and Artemyev, 1996).
Heterogeneity in the noncatalytic cGMP binding sites was readily observed
(Figure 2.IB) when bound [3H]cGMP dissociated from taPDE (but not nPDE), in
agreement with previous observations (Cote et al., 1994; Yamazaki et al., 1996a; Calvert
et al., 1998). PDE activation accelerates 9-fold the exchange rate o f cGMP from
approximately 0.4 cGMP per PDE, probably reflecting the low affinity sites that are not
saturated under the conditions o f this experiment. The remaining two-thirds o f the
binding sites (0.8 cGMP per PDE) dissociate bound [3H]cGMP at the same rate as does
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Figure 2.1. The kinetics o f cGMP exchange at the noncatalytic sites o f non-activated and
transducin-activated PDE. A. For measuring the kinetics o f cGMP association to nPDE,
25 nM PDE was mixed with 1 fiM [3H]cGMP at 4°, and the binding reaction quenched
with ice-cold ammonium sulfate at the indicated times (see “Experimental Procedures”).
Transducin-activated PDE (taPDE) was prepared from non-activated PDE (nPDE) by
pre-incubating samples with 1 mM GTPyS for 1 min prior to cGMP addition. The nPDE
data are the mean ± S.E.M. for 6 experiments, and the curve is the fit o f the data to a
pseudo first-order reaction (kobs = 7.7 ± 0.8 x 10'2 sec'1; Bmax = 1.83 ± 0.07 cGMP bound
per PDE). For taPDE, the values are: kobs = 7.9 ± 0.8 x 10'2 sec'1; Bmax = 1.25 ± 0.08
cGMP bound per PDE; n = 7). Note that a two-site model was not statistically preferred
to the one-site model in all experiments examined. B. To measure the kinetics o f cGMP
dissociation, 60 nM PDE (either non-activated or pre-incubated for 1 min with GTPyS as
above) was first incubated with 1 jjM [3H]cGMP for 30 min at 4° to occupy the
noncatalytic sites (nPDE: 1.7 cGMP bound per PDE; taPDE: 1.2 cGMP bound per PDE).
At time zero, dissociation o f [3H]cGMP was initiated by addition o f 10 mM unlabeled
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cGMP, and samples were directly filtered at the indicated times. The data points are the
mean ± SEM (n = 6), and the curves represent the fit o f the data to a single exponential
for nPDE (k_i = 3.4 x 1CF* sec"1) and a double exponential process for taPDE (36% fast
sites, k_i = 2.9 x 10"3 sec'1; 64% slow sites, k_i = 3.4 x 10"4 sec"1). The dotted line
demonstrates that the data for taPDE dissociation do not fit a single-site dissociation
model.

nPDE. Thus, a 7-fold change in the K d o f the moderate affinity cGMP binding sites
following transducin activation o f PDE fails to significantly affect the dissociation rate
constant from these sites. The approximately 1000-fold lowering o f cGMP affinity to the
second class o f sites on taPDE has a relatively modest effect on the dissociation rate
constant for this class o f noncatalytic sites detected in Figure 2. IB.
We conclude that the nonactivated PDE holoenzyme consists o f two identical,
high affinity cGMP binding sites. Furthermore, the excellent agreement between the
observed K d and the kinetic K d (k.i/k+i = 4.5 nM) indicates that the association and
dissociation reaction steps measured in Fig. 2.1 represent the rate-limiting steps for
cGMP interaction with the noncatalytic sites on nPDE. Upon transducin activation o f
PDE, heterogeneity in the noncatalytic sites becomes evident. The moderate affinity
noncatalytic site on taPDE (Kd = 57 nM) retains the same kinetic rate constants for
cGMP association and dissociation as observed for nPDE, indicating that some other
rate-limiting process (e.g., conformational transition, protein-protein interaction, etc.)
must contribute to destabilizing cGMP binding to this class o f sites. The low affinity site
can only be saturated at high cGMP concentrations (well above micromolar), and
represents the small proportion o f more rapidly dissociating sites in Figure 2. IB . The
creation o f two non-identical cGMP binding sites on upon PDE activation by transducin
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is likely to result from differences in how a t-GTPyS interacts with the a and p catalytic
subunits.

Exogenous P y regulates cGMP exchange rates at both low and high affinity
noncatalytic sites on PDE. To test the role o f Py to regulate cGMP binding to the
noncatalytic sites on nPDE and taPDE, we examined whether adding Py affected cGMP
dissociation from nPDE and taPDE. Figure 2.2A shows that when nPDE is incubated
with increasing amounts o f Py and then 1 pJvl [3H]cGMP is added to occupy the
noncatalytic sites, the half-time for [3H]cGMP release is progressively slowed. The
ability o f Py to slow cGMP dissociation from nPDE is probably a consequence o f
reducing (by mass action) the number o f PDE molecules lacking one or two bound Py at
any moment in time. The sensitivity o f cGMP exchange on nPDE to the free Py
concentration suggests a strong allosteric linkage between Py binding to PaP and cGMP
occupancy o f the noncatalytic sites.
Pre-incubation o f taPDE with increasing amounts o f Py prior to transducin
activation has two major effects on the noncatalytic cGMP binding sites. First, Py can
convert low affinity cGMP binding sites on taPDE to high affinity sites (Figure 2.2C).
Second, addition o f increasing amounts o f Py can reduce (1 Py added per taPDE) or
abolish (> 2 Py added per taPDE) the rapidly dissociating class o f noncatalytic sites on
taPDE, as well as slowing cGMP dissociation from the other class o f sites to a similar
extent as nPDE (Figure 2.2B). It is noteworthy that Py exerts these effects on the
noncatalytic cGMP binding sites with greater potency than it can inhibit catalysis at the
active site o f taPDE (see Figure 2.7).
33
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Figure 2.2. Effects o f exogenous Py on cGMP dissociation from noncatalytic sites and on
the maximum extent o f cGMP binding to nPDE and taPDE. ROS homogenates (20 nM
PDE, final concentration) were incubated at 4° for —4 min with the following
concentrations o f Py: 0 (circle), 1.0 (square), 2.0 (triangle), 5.0 (diamond) or 20 (upsidedown triangle) mol Py per mol PDE. For transducin-activated PDE (panel B), the ROS
were then incubated with 1 mM GTPyS for 1 min. Following addition o f 1 pM
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[3H]cGMP for 30 min at 4°, samples were tested for the maximum extent o f cGMP
binding (panel C). [3H]cGMP dissociation was initiated upon addition o f 10 mM
unlabeled cGMP at time zero and then portions were directly filtered at the indicated
times. For nPDE (panel A), the data were best fit to a single exponential decay with the
dissociation rates progressively slowing from the control value o f t\n = 34 m in to a t\a =
196 min for the 20 Py per PDE condition. For taPDE, a two-site model for the
dissociation kinetics was preferred for the 0 and 1 Py per PDE conditions, with the
percentage o f the total binding that can be attributed to the “fast” sites d im in ish in g from
35% to <10% as the amount o f added Py increased from 0 to 2 Py per PDE. The data are
the mean ± SEM for three to six determinations o f the dissociation rates for each
concentration o f added Py.

Quantitative analysis o f the P y concentration and its subcellular location in
purifiedfrog ROS. Because free Py greatly affects cGMP binding and exchange kinetics
with PDE, we decided to measure the Py concentration in intact frog ROS as well as the
stoichiometry o f Py binding to frog Pap. Using a quantitative immunoblot procedure, we
found that homogenates derived from Percoll-purified frog ROS contained 1.81 ±0.13
(mean ± S.E.M.; n = 14) mol o f Py relative to the total concentration o f PDE holoenzyme
(Figure 2.3, “Homog.”). Upon fractionation o f these ROS homogenates into membrane
and soluble fractions by centrifugation, both dark-adapted and light-exposed ROS
retain all Py (1.9 —2.0 Py per PaP) in a membrane-associated state, and < 0.1 Py per P aP
in the soluble fractions (Figure 2.3, “Control”). The membrane-associated Py was bound
to PDE, because when frog PDE was released from ROS membranes by hypotonic
extraction, a similar stoichiometry o f Py binding to the released PDE was observed (data
not shown).
Addition o f cGMP to saturate the noncatalytic sites on PDE did not alter the
membrane-associated state or stoichiometry o f Py binding to dark-adapted or light-
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+GTPyS +cGMP &
GTPyS
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Figure 2.3. Py content o f membrane and supernatant fractions o f frog ROS homogenates.
ROS homogenates (120 nM PDE holoenzyme) in Buffer A were incubated at 4° for 30
sec with: no additions (“Control”), 2.2 mM cGMP (“+cGMP”), 50 jrM GTPyS
(“+GTPyS”), or both nucleotides supplemented with 50 jjM zaprinast (“+cG&GTPyS”).
Identical portions were either kept dark-adapted (black bars) or exposed to room light
(gray bars) during the incubation period, and then samples were centrifuged for 1 min at
110,000 x g at ambient temperature. Supernatant (s) and membrane (m) samples were
processed on different gels, along with a set o f Py standards on each gel, to quantitate the
Py content (see “Experimental Procedures”). Unfractionated, dark-adapted ROS
homogenates with no additions (“Homog.”) were also analyzed along with the membrane
samples for the sake of comparison. In the representative immunoblot shown in the
figure, the supernatant samples were exposed to film for longer times than the membrane
samples to permit detection o f lower amounts o f immunoreactivity. The * indicates that
the amount o f Py was below the level o f detection. The data represent the mean ± S.E.M.
for three experiments with different ROS homogenates. This figure was done in
collaboration with Tracy Hebert and Marc D ’Amours.

exposed PDE (1.9 - 2.0 Py per P ap ; Figure 2.3, “+cGMP”). However, if light-exposed
ROS homogenates are incubated with GTPyS to activate transducin, a substantial release
o f Py into the supernatant fraction occurs shortly after nucleotide addition (0.8 ± 0.1 mol
Py released per mol PaP). This Py dissociation into the supernatant can be prevented if
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millimolar levels o f cGMP are included with GTPyS (0.1 Py released per Pap; Figure
2.3). Our quantitative analysis o f Py agrees with and extends the qualitative observations
o f Arshavsky et al. who first showed that occupancy o f the noncatalytic sites by cGMP
could prevent Py release from ROS membranes following transducin activation
(Arshavsky et al., 1992).
We conclude that the frog rod PDE holoenzyme consists o f a P aP catalytic dimer
to which 2 Py subunits bind, identical to the apyi stoichiometry o f membrane-associated
bovine rod PDE holoenzyme (Deterre et al., 1988; Fung et al., 1990). The absence o f Py
in the ROS cytosol may reflect a tightly regulated, coordinated synthesis o f catalytic and
inhibitory subunits o f PDE [as suggested by Py knockout experiments (Tsang et al.,
1996)]. The fact that approximately 1 mol Py per mol P ap can be released within 1 min
o f light activation o f PDE (Figure 2.3, “+GTPyS” condition) led us to hypothesize that
the state o f association o f Py and cGMP with the PDE holoenzyme m ay be tightly
coupled upon PDE activation by transducin.

cGMP dissociation from noncatalytic sites correlates with P y release following
transducin activation o f PDE. To test whether cGMP dissociation from noncatalytic sites
is directly correlated with Py release from taPDE, we examined the time course o f cGMP
dissociation and o f Py release following transducin activation o f PDE under conditions
where the free cGMP concentration was rapidly reduced from its “dark-adapted”
concentration (2 |iM). To activate PDE and simultaneously lower the free cGMP
concentration, we employed a “concentration jump” technique (Calvert et al., 1998) in
which GTPyS was added (to activate frog rod PDE) along with activated PDE1 (to
37
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rapidly hydrolyze free cGMP). Release of Py and cGMP from PDE were determined by
centrifugation o f samples through silicone oil and analysis o f the pellets for the amount o f
[3H]cGMP or Py bound to the membrane-associated PDE. We found that the time course
o f cGMP dissociation following transducin activation closely tracked the rate o f Py
release (Figure 2.4). Both processes showed biphasic dissociation kinetics, with 20-30%
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Figure 2.4. Py dissociation from transducin-activated PDE correlates with cGMP
dissociation from noncatalytic binding sites. ROS homogenates (30-120 nM PDE) were
incubated with 2 pM cGMP or [3H]cGMP and 3 pM E4021 for 10 min at 4°. Transducin
activation o f PDE and dissociation o f its bound cGMP was initiated upon addition o f 100
pM GTPyS, 103 U/l PDE1, and 8xl04 U/l calmodulin (final concentrations). [In control
experiments similar to those o f Calvert et al., Fig. 5A (Calvert et al., 1998), we
determined that PDE1 activities ranging from 500 to 4000 U/l resulted in identical cGMP
dissociation kinetics.] At the indicated times, portions were centrifuged for 1 min at
110,000 x g at room temperature. The membrane pellet was then analyzed for either Py
content (•) or [3H]cGMP binding (o). The data points represent the mean ± S.E.M. for
four experiments where Py and [3H]cGMP were both measured on the same preparation.
The curves represent the fit o f the data to a 2-site binding model: for Py release: 30 ± 5%
o f the Py rapidly dissociated (tj/2 = 0.6 ± 0.2 min) and 70 ± 3% o f the Py slowly
dissociated (tj/2 = 39 ± 6 min); for cGMP dissociation, 20 ± 7% was rapidly released (ti /2
= 0.7 ± 0.6 min) while 80 ± 5% slowly dissociated (ti /2 = 65 ± 15 min). This figure was
done in collaboration with Tracy Hebert and Marc D ’Amours.
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o f the reaction occurring rapidly (t\n = 0.6 - 0.7 min), and the remainder o f the
dissociation reaction occurring much more slowly (ti/2 = 40-60 min).
Experimental limitations prevented us from determining the temporal sequence o f
Py and cGMP dissociation from P ap . However, it is likely that interaction o f a t-GTPyS
with Py bound to the PDE holoenzyme initially displaces Py from its tight association
with one catalytic subunit, thereby accelerating cGMP dissociation from the noncatalytic
site. Loss o f cGMP at this noncatalytic site would further lower the Py binding affinity
for P ap, leading to dissociation o f P y -at-GTPyS from P a p . The observation that cGMP
and Py dissociation from the other class o f binding sites proceeds as slowly as for nPDE
(Figure 2.IB) indicates that a t-GTPyS is much less effective in binding to the second Py
molecule and accelerating cGMP exchange at this noncatalytic site. This might be
explained if the remaining Py bound with higher intrinsic affinity to P aP than the Py that
is rapidly released.

c GMP occupancy o f the noncatalytic sites induces stoichiometric binding o f P yto
taPDE. We next asked whether occupancy o f the noncatalytic cGMP binding sites on
taPDE was sufficient to reverse Py dissociation from P ap . We first prepared taPDE
lacking bound cGMP, and then added increasing concentrations o f [3H]cGMP. After
centrifuging the PDE-containing ROS membranes, we simultaneously assayed the extent
o f [3H]cGMP binding and the stoichiometry o f Py binding to taPDE. Figure 2.5
demonstrates a one-to-one correlation between cGMP occupancy o f the high affinity
noncatalytic sites and Py binding to P ap. In the absence o f cGMP, taPDE bound 0.2 mol
Py per mol PDE. As increasing concentrations o f cGMP were added, taPDE displayed a n

39

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

= 4) and a single class o f Py binding sites (Bmax = 1.4 ± 0.1 Py bound per PDE; n = 4).
When incubated with high concentrations o f cGMP to occupy both high and low affinity
cGMP binding sites on taPDE, the Py binding stoichiometry approached the same value
as for nPDE (Figure 2.3, “+cGMP & GTPyS”).
We conclude that cGMP occupancy of the noncatalytic sites must induce a
conformational change in the P aP catalytic dimer that enhances Py binding to P ap . This
allosteric effect o f cGMP to enhance Py binding affinity does not act on the C-terminal
inhibitory domain o f Py (Granovsky et al., 1997), because taPDE remains catalytically
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Figure 2.5. Endogenous Py binding to transducin-activated PDE correlates with titration
o f cGMP binding to the noncatalytic sites. PDE (15 nM) was transducin-activated by the
addition o f 10 pM GTPyS 1 minute prior to the addition o f increasing amounts o f
[3H]cGMP (with 200 pM zaprinast). After a 30 min incubation, two portions were
quenched into ice-cold buffered ammonium sulfate (see Experimental Procedures) to
determine the [3H]cGMP content (closed circle). The remaining portion was spun for 1
min at 110,000 x g. The supernatants were discarded, and the pellets were washed once
and then analyzed for their Py content (open circle). For the cGMP binding data, the
curve is a 2-parameter hyperbolic fit with Bmax = 1.3 cGMP bound per PDE and a Kd =
65 nM, while the Py binding curve parameters are: Bmax = 1.1 Py per PDE and K 1/2 = 34
nM cGMP. The data shown are representative of 4 individual experiments.
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single class o f high affinity cGMP binding sites (Bmax = 1.3 ±0.1 cGMP bound per PDE;
activated (see Table 2.2). Rather, a distinct domain on Py [e.g., the central polycationic
domain; (Artemyev and Hamm, 1992)] must be involved in interacting w ith PaP in a
cGMP-dependent manner.

Two distinct classes o f Py binding sites on Paf5 restore high affinity cGMP
binding to the noncatalytic sites. To understand the basis o f the heterogeneity in the
noncatalytic sites o f taPDE, we needed to study the binding o f cGMP and Py to catalytic
dimers (Pap) from which Py had been completely removed. Previous work had
demonstrated that physical removal o f Py from frog rod PDE following transducin
activation resulted in a loss o f cGMP binding, and that addition of Py restored high
affinity cGMP binding to noncatalytic sites (Yamazaki et al., 1982; Cote et al., 1994;
Yamazaki et al., 1996b). However, heterogeneity in Py binding to frog P a P has been
reported in some cases (Yamazaki et al., 1996b; Yamazaki et al., 1996a) but not in others
(Yamazaki et al., 1982; Cote et al., 1994).
Two independent approaches were used to prepare P aP catalytic dimers from
which Py had been removed. The first method is based on the ability o f activated
transducin to release 50 - 70% o f its Py when the noncatalytic sites are empty (Yamazaki
et al., 1990). [We further optimized the conditions for Py removal from P a P to further
reduce the amount of Py associated with PaP to 10 —25% o f the original amount (see
“Experimental Procedures” and Fig. 2.4).] The second approach to preparing P aP dimers
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relied on the ability o f trypsin proteolysis to degrade Py without adversely affecting the
functional properties o f P ap at its catalytic or noncatalytic sites (Mou et al., 1999).
Figure 2.6 demonstrates that when we prepared P ap catalytic dimers by either
method, addition o f Py to PaP in the presence o f 1 pM [3H] cGMP restores high affinity
cGMP binding to the noncatalytic sites in a biphasic manner. Addition o f < 1 mol Py per
PaP results in equimolar cGMP binding to high affinity sites on P ap. Thereafter, only a
slight increase in cGMP binding is observed in the range o f 1 - 2 Py added per PaP- It is
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Figure 2.6. The restoration o f high affinity cGMP binding to PDE catalytic dimers by Py
reveals two classes o f binding sites. Activated PDE was prepared either by extraction o f
Py from P a p by a t-GTPyS (closed circles, n = 5) or by trypsin proteolysis (2.5 pg/ml
trypsin for 5 min at 4°) to make tPDE (open circles, n = 3), as described in “Experimental
Procedures”. The residual Py content was 16 ± 2% for PaP, and 22 ± 2% for tPDE. The
indicated concentration o f Py was incubated with 10 nM PaP (closed circles) or 17 nM
tPDE (open circles) for 5 minutes before adding 1 pM [3H]cGMP plus 200 pM zaprinast.
The samples were incubated for 30 min at 4°, then analyzed for the amount o f [3H]cGMP
bound to the enzyme. The dashed line represents the results that would have been seen if
the restoration o f high affinity cGMP binding by Py occurred in a simple one-to-one
stoichiometry.
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noteworthy that adding exactly 2 mol exogenous Py per mol P aP in Figure 2.6 leads to
the same extent o f cGMP binding (1.2 cGMP per PDE) as is seen for taPDE samples
(containing 2 mol endogenous Py per mol PDE) under similar conditions (Table 2.1,
Figure 2.2C, Fig. 2.5). Addition o f > 4 Py per P a p fully restores cGMP binding to a
second class o f sites that were unoccupied at lower Py concentrations (consistent with the
results in Figure 2.2C for taPDE). The results shown in Figure 2.6 were also observed
when PaP was prepared by activating transducin with GTP instead o f GTPyS (data not
shown). The data in Figure 2.6 are in good agreement with previously published data
(Cote et al., 1994); the more extensive data set and greater precision in determining PDE
subunit concentrations in Figure 2.6 probably account for our ability to resolve the
biphasic behavior that was overlooked in the earlier study.
The results in Figure 2.6 demonstrate that P a p contains two distinct classes o f Py
binding sites. One class o f Py binding sites has very high affinity for PaP in the presence
o f 1 jjM cGMP, and can bind up to 1 Py per PaP as a simple titration phenomenon. The
noncatalytic cGMP binding sites that are restored by stoichiometric Py addition
correspond to the moderate affinity class o f sites found in taPDE (Table 2.1, Figure 2.5).
The second class o f Py binding sites on PaP are o f lower affinity and requires an excess
o f Py (when the cGMP concentration is < 1 pM) in order to shift the equilibrium to the
liganded state. This lower affinity class o f Py binding sites is very likely responsible for
converting low affinity noncatalytic cGMP binding sites on taPDE to their high affinity
state (Figure 2.2C). Although it is probable that the a and P catalytic subunits o f frog
PDE have binding domains for Py with intrinsically different binding affinities [as
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reported for Py binding to bovine rod PDE; (Berger et al., 1999)], we cannot rule out
allosteric mechanisms that might induce heterogeneity in Py binding to Pa(3.

Transducin activation fails to stimulate the maximum catalytic potential o f the
P a p catalytic heterodimer. Based on the above results, we hypothesized that
heterogeneity in Py binding to P a p might also result in differences in catalysis at the two
active sites on P ap . While most previous work has assumed that each catalytic subunit
contributes equally to catalysis upon activation o f PDE by transducin, there is wide
variation in the reported maximal hydrolytic rates for activated PDE [see Table V in
(Pugh, Jr. and Lamb, 1993)] as well as uncertainty in the stoichiometry and cooperativity
o f transducin activation o f PDE [see (Melia et al., 2000) and references cited therein].
We compared the rates o f cGMP hydrolysis for various forms o f activated PDE
that differed in the method by which the inhibitory constraint o f Py was relieved. To
determine the maximum hydrolytic rate of taPDE, we measured the enzyme activity in
light-exposed ROS homogenates following addition o f increasing concentrations o f
GTPyS. Complete activation o f PDE by transducin required a concentration o f GTPyS
sufficient to activate the entire pool o f transducin in ROS (data not shown). The kcat for
taPDE, 4560 ± 140 cGMP per s (Table 2.2) is not significantly different from a previous
estimate o f 4400 cGMP per s (Dumke et al., 1994).
We used the same frog ROS homogenates to directly compare taPDE with PDE
activated by trypsin proteolysis (tPDE). We found that the kcat in the latter case was
substantially higher, in contrast to previous comparisons using frog PDE (Whalen and
Bitensky, 1989; Whalen et al., 1990). In one set o f experiments where we added
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increasing concentrations o f trypsin to 2 nM PDE, we found a maximum catalytic rate o f
7640 ± 1 4 0 cGMP hydrolyzed per s (n = 5; data not shown). In additional experiments
where hydrolytic activity measurements were m ade at relatively low tPDE concentrations
(0.5 to 3 nM PDE), we observed similarly high rates (Table 2.2). I f hydrolytic activity o f
tPDE was assayed at substantially higher enzyme concentrations (15 —30 nM tPDE), the
maximal rate approached the kcat for taPDE (Table 2.2). In a separate experiment,

Table 2.2
Sum m ary

of

M a x im a l A c t iv it ie s

V a r io u s P r e p a r a t io n s

1 2 -2 0

Maximum catalytic activity0
n
(cGMP per s per PDE)
4400
ref.
(Dumke et
al., 1994)
10
4560 ± 140

0.02

7 8 7 0 ± 150

0 .5 -3 .0
1 5 -3 0
1 -2

7 5 5 0 ± 110
4990 ± 375
7000 ± 1 8 0 d

[PD Ef
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> 12
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Pap

of

F r o g PDE

A c tiv a te d

PDE preparation3

for

ref.
(D'Amours
and Cote,
1999)
23
5
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aPDE activated by transducin (taPDE), trypsin proteolysis (tPDE), or Py extraction by a tGTPyS (PaP) was prepared as described in the “Experimental Procedures.”
bThe concentration o f PDE used to assay the hydrolytic rate.
'Determ ined by measuring catalysis in the presence o f saturating levels o f cGMP (~100
times the K m). The values are normalized to the concentration o f PDE catalytic dimer in
each instance.
dThe maximal rate was calculated by correcting the observed rate in each experiment for
the residual Py (15 - 25%) remaining bound to P aP , assuming a linear dependence o f the
observed rate with the Py content (see Fig. 2.7).
This table was done in collaboration with Marc D ’Amours.
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progressive dilution o f tPDE from 3 nM to 0.5 nM caused the hydrolytic activity to
increase from 6400 to 8100 cGMP per s per PDE; further dilution to 6 pM tPDE had no
further effect on the apparent kcat- We attribute this phenomenon to the presence
o f proteolytic fragments o f Py in our tPDE preparations that retain the ability to bind to
and inhibit P a p at high, but not low, PDE concentrations. A 4.6 kDa Py-immunoreactive
band [corresponding to amino acids 46 to 87 o f bovine Py (Artemyev and Hamm, 1992)]
has been detected on immunoblots o f tPDE preparations, and co-purifies with tPDE
following gel filtration chromatography (data not shown).
We have also measured the maximal cGMP hydrolytic rates o f PaP preparations
in which 75 - 85% o f the endogenous Py has been extracted by a r GTPyS. We find
catalytic rates substantially greater (range, 5000 - 6600 cGMP per s) than the kcat for
taPDE. When corrected for the residual Py content o f these P aP preparations, the
predicted kcat o f P aP dimer devoid o f Py is 7000 ± 1 8 0 cGMP per sec (n = 8; Table 2.2).
Trypsinization o f these P aP preparations containing residual Py can further elevate the
hydrolytic rate approximately 25%.
We conclude that the maximum catalytic potential o f the P aP catalytic dimer
approaches 8000 cGMP hydrolyzed per s per P a P when all Py is released from the
enzyme. If we assume each catalytic subunit has the same turnover number (4000 cGMP
per s per subunit) and the KM for tPDE is 22 pM (D'Amours and Cote, 1999), the
specificity constant, kcat/KM is calculated to be 1.8 x 108 M 'V 1. Thus, the catalysis o f
cGMP into 5’-GMP occurs with extremely high catalytic efficiency and very near the
diffusion limit (Gutfreund, 1995). However, PDE never achieves this level o f activation
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in vivo, because transducin activation of the enzyme fails to fully relieve Py inhibition at
both active sites. Rather, a t-GTPyS acts to completely relieve inhibition at only one o f the
two active sites on P a p , with perhaps a minor (< 10%) effect at the second catalytic site.
Activation o f PDE catalysis by one, not two, activated transducin molecules in frog ROS
homogenates is consistent with the 1:1 stoichiometry o f bovine rod PDE activation by
transducin in a purified, reconstituted system (Melia et al., 2000).

Exogenous P ycan stoichiometrically inhibit Pa{3 catalytic dimers, but not taPDE.
To further probe how transducin binds to and activates the PDE holoenzyme, we
examined the ability o f exogenous Py to inhibit the various forms o f activated PDE used
in this paper. Previous studies using tPDE or Pap preparations offer conflicting views on
the ability o f Py to inhibit activated frog PDE. In some reports, activated PDE can be
inhibited by Py as a single class o f high affinity sites (Yamazaki et al., 1996b; Yamazaki
et al., 1996a), exhibiting the same titration behavior observed with bovine tPDE [e.g.,
refs. (Wensel and Stryer, 1986; Brown and Stryer, 1989; Mou et al., 1999)]. Other studies
with activated frog PDE show evidence for lower affinity Py binding and/or complex
inhibition o f catalysis by added Py (Yamazaki et al., 1982; Whalen and Bitensky, 1989;
Yamazaki et al., 1990). These differing results may arise from a number of factors,
including the concentration o f PDE catalytic subunits used, residual Py in the activated
PDE preparations, and uncertainties in determining the active P a p and/or Py
concentrations.
To resolve these discrepancies, we examined the ability o f Py to inhibit activated
PDE under conditions where the catalytic and inhibitory subunit concentrations were
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precisely determined. Figure 2.7 shows that PDE activated by transducin responds quite
differently to the addition o f Py than do tPDE or P a p preparations. Both tPDE and P aP
are stoichiometrically inhibited by 2 mol Py per mol Pap. The steep linear dependence o f
tPDE and PaP activity on the Py concentration reflects a titration phenomenon consistent
with the sub-nanomolar binding affinity o f Py for frog PDE reported previously
(D'Amours and Cote, 1999). The similar behavior for tPDE and P a P in Figure 2.7 shows
that trypsinization o f PDE acts primarily on Py and has no noticeable effect on the ability
o f PaP subunits to be inhibited by added Py. Although a t-GTPyS is present in our PaP
preparations (see “Experimental Procedures”) and is capable o f binding free Py
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Figure 2.7. Stoichiometric Py inhibition o f catalysis is observed with tPDE and PaP, but
not with taPDE. tPDE (5 nM) was activated by trypsin treatment (200 pg/ml trypsin for
10 min at 4°; see Experimental Procedures) and then incubated with the indicated amount
o f Py. taPDE was prepared by first incubating nPDE (30 nM) with the indicated amounts
o f Py for 2 min prior to addition of 1 mM GTPyS for 1 min at 22°. P a P dimers depleted
o f >70% o f its endogenous Py was prepared by two successive extractions o f Py with
GTPyS followed by centrifugation (see Experimental Procedures). P a P (1 nM) was then
incubated with the indicated concentrations o f exogenous Py. PDE catalytic activity was
measured with 10 mM cGMP as substrate, and the rates normalized to the maximum
value obtained in the absence o f added Py. The curves represent a 3-parameter logistic
curve fit to the data with IC 5 0 values o f 0.9, 0.9, and 7.1 Py per PDE for tPDE, PaP, and
taPDE, respectively.
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(Yamazaki et al., 1990), the stoichiometric inhibition o f P aP by Py demonstrates that a t- ■
GTPyS cannot compete effectively with PaP for binding to Py under these conditions.
Thus, in both instances where activated PDE has had its Py physically removed from the
catalytic dimer, exogenous Py has free access to and high affinity for the catalytic sites
and can stoichiometrically inhibit catalysis.
In contrast, the inhibition o f taPDE by addition o f Py requires a greater than 15fold molar excess o f Py to fully inhibit catalytic activity (Figure 2.7). The potency o f Py
inhibition at the active site is several-fold weaker than its ability to convert low affinity
noncatalytic binding sites on taPDE to higher affinity sites (Figure 2.2C). Note that in the
presence o f millimolar levels o f cGMP in Figure 2.7, taPDE binds 2 mol endogenous Py
per mol PDE (Figure 2.3), and has a catalytic activity about one-half of the maximal rate
o f PaP (Table 2.2). It is likely, therefore, that taPDE exists as a complex o f a t-GTPyS
with the PDE holoenzyme. We speculate that a molecule o f a t-GTPyS, in a complex with
Py and a catalytic subunit, hinders the free diffusion o f exogenous Py to its inhibitory
binding site, thereby reducing the effectiveness o f free Py to inhibit cGMP hydrolysis
compared to tPDE or P a p preparations.

Role o f the noncatalytic cGMP binding sites during transducin activation ofPD E.
Our results suggest that the noncatalytic sites on photoreceptor PDE detect changes in
cytoplasmic cGMP concentration during phototransduction, and allosterically regulate
the state o f association o f Py with PDE and with activated transducin. In the dark-adapted
state, cGMP levels in rod photoreceptors are much higher (> 1 pM) than the Kd for
cGMP binding to the noncatalytic sites of nPDE. Consequently, Py remains bound to both
49
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Figure 2.8. Model for activation o f rod photoreceptor PDE holoenzyme by transducin.
The nonactivated form o f the PDE holoenzyme (nPDE) is depicted with the right-hand
catalytic subunit having a higher affinity for Py. Following binding o f activated
transducin (ar*) to the PDE holoenzyme, the inhibitory constraint o f Py is released at the
active site (notch) on the left-hand catalytic subunit (lower Py binding affinity). In the
presence o f high cGMP concentrations, noncatalytic sites (semi-circles) remain occupied
and Py remains bound to both subunits (“taPDE-A”). Lowering the cGMP concentrations
causes a transition to taPDE-B in which cGMP dissociates from its low affinity
noncatalytic site (left side), and Py dissociation accompanies cGMP release. The righthand subunit o f taPDE-B retains bound cGMP and Py because o f its intrinsically higher
binding affinity for both molecules, and little relief o f inhibition occurs at this active site.
See text for details.

catalytic subunits in its inhibitory conformation, and cGMP and Py exchange between the
bound and free states is expected to be very slow (Figure 2.8, “nPDE”).
Transient light activation o f the visual excitation pathway causes activated a t to
displace Py from its inhibitory conformation, and cGMP rapidly drops below micromolar
levels. However, the recovery of the dark-adapted state in response to dim flashes (time
scale, seconds) probably restores cGMP levels (via guanylate cyclase activation) more
rapidly than cGMP can dissociate from noncatalytic sites. Under these conditions,
activated PDE would consist o f a complex o f PDE holoenzyme (both noncatalytic sites
occupied, both Py bound to PaP, and one catalytic site fully active; Figure 2.8, “taPDE-
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A”) and activated a t. PDE inactivation would depend upon the intrinsic GTPase rate o f
transducin converting activated a t-GTP to inactive a t-GDP.
Persistent activation o f the phototransduction cascade by continuous illumination
or bright flashes o f light causes cytoplasmic cGMP levels to remain below the K d for the
low affinity sites on taPDE long enough for cGMP to dissociate from the low affinity
noncatalytic sites. Py dissociation will occur at the same rate because o f the highly
cooperative nature o f Py and cGMP binding to PDE (Figure 2.8, “taPDE-B”)- The Py that
is released is known to serve as a GTPase-accelerating factor for a t-GTP— in
combination with the Regulator o f G-protein Signaling-9 (RGS-9) and the G-protein Psl
subunit (Arshavsky and Bownds, 1992; He et al., 1998; Makino et al., 1999). This would
speed up transducin inactivation, diminish the amplitude of the light response, and act as
a feedback regulator for light adaptation.
Our model predicts that the second catalytic subunit o f the PDE holoenzyme
remains relatively unaffected by activation o f the rod phototransduction cascade, in terms
o f catalytic activation, Py release, or cGMP dissociation (Figure 2.8, right-hand subunit).
Only under certain in vitro conditions does this subunit undergo changes in ligand
binding or catalytic activity. A higher intrinsic affinity o f this catalytic subunit for Py may
account for this phenomenon.
Additional experiments are needed to test the hypothesis that the noncatalytic
sites on PDE serve as a detector o f the cGMP concentration in rod photoreceptors during
light adaptation. Future work will focus on better understanding the properties o f the low
affinity noncatalytic sites on activated PDE, identifying the structural basis for catalytic
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subunit heterogeneity, and examining whether the homodimeric cone PDE employs
similar regulatory mechanisms in cone photoreceptors.
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CHAPTER 3

ROLE OF THE 17 kDa 5 PROTEIN AND IMMUNOLOGIC ALLY
RELATED PROTEINS IN REGULATION OF PDE IN ROD
PHOTORECEPTORS

Summary

In rod photoreceptors, the disk membrane is the site where photo-isomerization o f
rhodopsin by light leads to activation o f the photoreceptor phosphodiesterase (PDE) by
the heterotrimeric G-protein, transducin. The PDE holoenzyme (aPy 2 ) has been reported
to exist in both a membrane-attached and soluble form. Isoprenylation of the catalytic
subunit C-termini confers disk membrane association to PDE, while soluble PDE is
found to bind a 17 kDa 5 “subunit.” It has been proposed that 8 translocates PDE from
the disk membrane, reducing its ability to be activated by transducin, and desensitizing
the photoresponse. Using purified, intact amphibian rod outer segment (ROS)
suspensions whose physiological and biochemical properties are well-characterized, we
examined the occurrence, abundance, and regulatory significance o f the 17 kDa 5 protein
to regulate PDE in rod photoreceptors. The frog homologue o f 8 was cloned and
sequenced from a frog retinal cDNA library, and shows 83% amino acid identity to
mammalian 8. All o f the PDE in frog ROS is membrane-associated, but addition o f
recombinant frog 8 can solubilize PDE and prevent its activation by transducin.
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Antibodies to 5 detect several proteins present in frog retinal homogenates, but the
abundance o f the 17 kDa protein compared to PDE in purified frog ROS is low (<0.1 8
per PDE). Similarly low ratios o f 8 to PDE are observed in purified bovine ROS.
Immunocytochemical results show that 8 is localized to several retinal cell types, but not
to rod outer segments. Higher molecular weight S-immunoreactive bands observed in
frog and bovine ROS were analyzed for specific binding to PDE with negative results.
We conclude that frog rod photoreceptors do not utilize the 17 kDa 8 protein or
immunologically related proteins to regulate phototransduction. Although we cannot rule
out species differences in regulation o f phototransduction pathways by 8 in mammalian
and amphibian photoreceptors, our results suggest that 8 is not involved in
phototransduction in ROS and that its function in the retina remains to be determined.

Introduction
The surface o f the disk membranes of the outer segment is the initial site of visual
transduction in rod photoreceptors. Light entering the cell is absorbed by the visual
pigment, rhodopsin. The activation o f rhodopsin allows it to catalyze the exchange o f
GDP for GTP on the a-subunit o f the heterotrimeric G-protein, transducin (Ta). T aGTP dissociates from Tpy and activates the effector enzyme o f the pathway,
phosphodiesterase (PDE). PDE hydrolyzes cGMP, closing the cGMP-gated ion channels
and causing hyperpolarization o f the cell [for recent reviews, see Pugh, Jr. and Lamb,
(2000); Bums and Baylor, (2001)].
Rod photoreceptor PDE is composed of a catalytic dimer o f a and p subunits
(PaP) and two identical inhibitory y subunits (Py). The catalytic subunits each have one
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active site and one high-affinity noncatalytic cGMP binding site within the regulatory
GAF domain. Each catalytic subunit is post-translationally modified at its C-terminus
with an isoprenyl group that confers its ability to bind to the disk membrane [for review,
see (Cote, 2002)].
In bovine rod photoreceptor cells, a fraction o f the total PDE is found in a soluble
form (Gillespie et al., 1989; Florio et al., 1996), and co-purifies with a 17 kDa protein
that was named the 5 subunit o f PDE. PDE derived from cone photoreceptors also binds
8 and is not membrane-associated (Gillespie and Beavo, 1988). The bovine 8 protein is
highly conserved among mammals (99% sequence identity), and homologous proteins
are found in C. elegans (65% identity) and D. melanogaster (62% identity) (Florio et al.,
1996; Li et al., 1998; Lorenz et al., 1998; Adams et al., 2000). Interestingly, while the 8
protein is highly expressed in the retina, it is also found in many other tissues that do not
express photoreceptor PDE (Florio et al., 1996; Lorenz et al., 1998; Marzesco et al.,
1998; Wang et al., 1999). Furthermore, 8 can specifically interact with other proteins
unrelated to known phototransduction proteins, such as R abl3 (Marzesco et al., 1998),
the retinitis pigmentosa GTPase regulator (Linari et al., 1999b), and the Arf-like protein
Arl3 (Linari et al., 1999a).
Biochemical studies have shown that exogenous 8 can bind to bovine rod PDE
with high affinity, and cause release o f PDE from the disk membrane (Florio et al.,
1996). This solubilization o f PDE correlates with a decrease in the ability o f transducin to
activate PDE (Cook et al., 2001). The primary site o f interaction o f 8 with PDE is with
the prenylated, methylated C-terminus o f the catalytic subunits (Cook et al., 2000). It has
been proposed that the ability o f 8 to solubilize disk membrane-associated PDE in vitro
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may be physiologically important as a desensitization mechanism during light adaptation
(Cook et al., 2001).
To date, all studies o f the 5 protein’s interaction with photoreceptor PDE have
been carried out using light-exposed, frozen bovine retinas from which ROS were
isolated. Thus, the light history, degree o f ROS purity, and extent of loss o f ROS soluble
proteins is difficult to control. To address the physiological role o f 8 in regulating PDE
during phototransduction, we focused on amphibian ROS for several reasons: (1) ability
to control illumination conditions (diumal light-dark cycle, dark versus light-adapted
conditions); (2) ease of purification o f osmotically intact frog ROS retaining the full
complement o f soluble and membrane proteins (Cote et al., 1984; Biembaum and
Bownds, 1985; Hamm and Bownds, 1986), and; (3) ability to correlate biochemical
measurements with extensive electrophysiological data in the literature.
In this paper, we demonstrate that the frog 17 kDa homologue to the bovine 8
protein is expressed in frog retina, can bind to PDE, and releases it from the membrane in
vitro. PDE solubilization by recombinant frog 8 is shown to directly correlate with
uncoupling o f transducin activation o f PDE. 8 also has a significant effect on cGMP
binding to the noncatalytic sites o f PDE. However, quantitative analysis o f the
stoichiometry and localization o f 8 in retina and in isolated ROS demonstrates that there
is insufficient 8 to significantly affect the subcellular localization o f PDE. Other 8immunoreactive proteins are present in retinal extracts and in purified ROS. A 36 kDa, 8immunoreactive protein that is released from disk membranes along with PDE was found
to not interact with PDE with high affinity. These results cast doubt on the ability of 8 to
regulate PDE during visual transduction.
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Experimental Procedure
Materials- Frogs (Rana catesbeiana) were obtained from Niles Biologicals, and
maintained on a 12 h dark-light cycle for two weeks before use in experiments (Cote,
2000). Frozen bovine retinas were obtained from W.L. Lawson, and Ficoll-purified
bovine ROS from freshly isolated retinas (Schnetkamp, 1981) were a kind gift o f Dr. Paul
Schnetkamp (University of Calgary). [3H]cGMP was from PerkinElmer Life Sciences.
Membranes for filter binding assays and the polyvinylidene fluoride (PVDF) for
immunoblotting were obtained from Millipore. Reagents and substrates for
immunoblotting were from Pierce or from Bio-Rad. All other chemicals were obtained
from Sigma. Bovine GST-8 expression plasmid was a kind gift from Drs. Terry Cook
and Joe Beavo (University of Washington).

Cloning and expression o f frog 5- A frog (R. pipiens) retinal cDNA library was
prepared as described elsewhere (Li and Baehr, 1998). Frog 8 was cloned by screening
the cDNA library using bovine 8 as a probe. The resulting clone, fpdedl, contained a
2.7-kb cDNA insert in pBluescript SK. The 450 base pair coding region o f 8 was PCRamplified with primers 5 ’-GGATCCATGTCTAGTAATGAGCGA and 5 ’GAATTCTCAAACATAAAACAGCCTG, containing Bam HI and E coR l restriction
sites. The resulting PCR product was inserted into the TOPO cloning vector and then
transferred into the pGEX-KG expression plasmid. DNA sequencing o f both strands
confirmed the coding region to contain the authentic nucleotide sequence. The cloning
o f frog 8 was done by Ning Li and Wolfgang Baehr, University o f Utah Health Center.
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The pGEX-KG construct was transformed into the E.coli strain BL21 DE3.
Overnight cultures were diluted 1:20 and grown at 37° until the OD 600 reached 0.7, at
which point 1 mM isopropyl-(3-D-thiogalactopyranoside was added to induce protein
expression. Growth continued for 1 hour at 37°. Cells were pelleted by centrifugation,
washed, and the resuspended cell pellet was sonicated. Centrifugation removed the
membranes, and the extracted proteins were applied to a glutathione-agarose column,
closely following established procedures. Bound GST-5 was eluted, concentrated by
ultrafiltration (Millipore BioMax 15K MWCO filter) then cleaved with thrombin (4 hours
at 37°). The thrombin was removed with the Thrombin Cleavage Capture Kit (Novagen).
The 5 was purified from GST by passage over a glutathione-agarose column, and the
recombinant frog 5 was concentrated by ultrafiltration (Millipore BioMax 5K MWCO
filter). The concentration of 5 was determined with a colorimetric protein assay (Smith et
al., 1985) and agreed with spectrometric measurements at 280 nm. The purity o f the
protein was >95%, as judged by SDS-PAGE.

Preparation o f Rod Outer Segments (ROS)- Osmotically intact frog ROS were
purified on a discontinuous Percoll gradient exactly as described (Cote, 2000). Purified
ROS were homogenized in a pseudointracellular medium [LIM: 77 mM KC1, 35 mM
NaCl, 2.0 mM MgCl2, 1.0 mM CaCl2, 1 mM EGTA, 10 mM HEPES (pH 7.5), 2 mM
dithiothreitol, 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 1 pM leupeptin, and 1
pM pepstatin]. Endogenous nucleotides were depleted by incubation o f ROS
homogenates in the dark at room temperature for 30 minutes. For ROS isolated from
dark-adapted frogs, the rhodopsin concentration was determined using difference
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spectroscopy (Bownds et al., 1971). The concentration o f PDE in ROS from both darkadapted and light-adapted frogs was determined by a cGMP filter binding assay (see
below).
Bovine ROS from frozen retinas were purified in the dark on a discontinuous
sucrose gradient as previously described (McDowell, 1993). In some cases, the sucrosepurified ROS were removed from the sucrose gradient, resuspended in Ringers, and then
loaded on a discontinuous Percoll gradient for further purification. ROS were
homogenized in LIM at 4° in the dark. The concentration o f rhodopsin was determined
by difference spectroscopy. PDE concentration was determined by measuring the
maximum cGMP hydrolysis o f the PDE upon limited trypsin proteolysis (see below).
Subcellular fractionation o f ROS homogenates was performed by centrifugation
for 3 minutes at 110,000 x gaVat room temperature using a Beckman Airfuge. The
integral membrane protein, rhodopsin, was present in the supernatant at undetectable
levels and >95% o f the rhodopsin was recovered in the membrane pellet under this
condition.
To hypotonically extract PDE, ROS homogenates were spun down to remove
soluble proteins. The ROS membranes were washed in hypotonic buffer (5 mM Tris, 0.5
mM EDTA, 1 mM dithiothreitol) supplemented with 10 mM M gC h to reduce the amount
o f peripheral membrane proteins. Three consecutive washes o f the membranes with
hypotonic buffer lacking M gCk were done to extract the PDE from the membranes. The
first wash included a 10 minute incubation on ice before centrifugation. To extract PDE
using CHAPS detergent, ROS membranes were prepared as above, and then the
membrane pellet was resuspended in LIM containing CHAPS (final concentration o f 10

59

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

mM). This sample was incubated on ice for 10 minutes before centrifugation. Two more
extractions o f the membranes with 10 mM CHAPS were performed and the detergentsolubilized PDE pooled.

Immunoblot analysis o f the Sprotein in fro g ROS- Samples for immunoblot
analysis were added to electrophoresis sample buffer, followed by SDS-PAGE on a 12%
polyacrylamide gel. Proteins were transferred onto Immobilon-PSQ polyvinylidene
fluoride or nitrocellulose membranes. The membrane was blocked with 1% bovine
serum albumin in TTBS (20 mM Tris pH 7.6, 137 mM NaCl, 0.5% Tween 20) prior to
incubation with anti-5 antibodies. Anti-5 antibodies were generated in rabbits using the
following immunogens: FL antibody: full-length bovine recombinant 5; FD antibody: a
synthetic peptide consisting o f a.a. 4-12 o f the frog 5 sequence conjugated to KLH; BD
antibody: a synthetic peptide consisting o f a.a. 41-52 of the bovine 5 sequence. The
antibodies were affinity purified over a 5-Sepharose column, or by peptide-coupled
beads. Antibodies to PDE catalytic subunits (NC; 1:10,000 dilution), and transducin a
subunit (Santa Cruz Biotech., 1:10,000 dilution) were also used. Antibody binding was
detected using a goat anti-rabbit secondary antibody coupled to horseradish peroxidase
(1:5000 dilution), followed by incubation o f the membrane with peroxidase substrate
(Pierce SuperSignal West Pico Chemiluminescent Light). For quantitative analysis o f the
5 protein in frog and bovine ROS, a standard curve of known concentrations o f
recombinant frog or bovine 5 was run on the same gel as the sample o f purified ROS.
Quantitation o f immunoreactive bands was performed with the image analysis program,
Quantiscan (Biosoft).
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Immunocytochemistry- Fresh bovine eyes were obtained from the slaughterhouse.
The eyes were hemi-sected and the back portion o f the eyecup was gently everted to
expose the retina. This was immersed in 4% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.4). The eye was washed in ice-cold phosphate buffer and soaked in 30%
buffered sucrose. Cryosectioning o f the eye was performed, and the sections were
exposed to primary antibody (8, FL). The sections were washed and a secondary
antibody conjugated to a fluorescent marker was added. Digital images were acquired by
a confocal microscope. Images were cropped, enlarged, and contrast-enhanced with
Adobe Photoshop (Adobe Systems, San Jose, CA). Immunocytochemistry was
performed by Dr. N. Vardi, University o f Pennsylvania.

cGMP binding and PDE activity assays- The frog PDE concentration was
routinely determined by quantitating [3H]cGMP binding to PDE under standard
conditions where it has been established that 2 cGMP bind per PDE holoenzyme (Norton
et al., 2000). In brief, PDE-containing samples were incubated for 10 min at room
temperature with 1 pM [3H]cGMP, 200 pM zaprinast, and a 2-fold molar excess o f Py.
Samples were filtered on pre-wet nitrocellulose filters, immediately followed by three 1ml washes with ice cold LIM (Cote, 2000).
The rate o f transducin-activated PDE hydrolysis was measured by a coupledenzyme phosphate release assay (Cote, 2000). GTPyS (equal in concentration to the
amount o f rhodopsin) was added to the PDE sample for 1 minute prior to the addition o f
10 mM cGMP. For each experiment, rate measurements were obtained from at least 3
individual time points, during which time less than 30% o f the substrate was consumed.
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Measurements o f the activity were made in the following buffer: 100 raM Tris (pH 7.5),
10 mM MgCb, 0.5 mM EDTA, 2 mM dithiothreitol, and 0.5 mg/ml bovine serum
albumin. This PDE enzyme assay was also used to determine the PDE content o f various
bovine ROS samples. In this instance, the bovine PDE was treated with trypsin to fully
activate the enzyme (kcat = 5600 s '1) to estimate the enzyme concentration (Mou et al.,
1999).

Co-precipitation o f PDE and S - Four different antibodies were tested for their
ability to immunoprecipitate 5 or 5-like proteins. The FD, BD, and FL anti-5 antibodies
were coupled to protein A beads prior to use. The ROS1 PDE antibody (Hurwitz et al.,
1984) was coupled to Sulfolink beads (5 mg/ml). For immunoprecipitation, solubilized
PDE was added to the antibody-coupled beads and incubated for 1-2 h at 4°. The beads
were then washed with TMN buffer (10 mM Tris pH 7.5, 1 mM M gCk, 300 mM NaCl, 1
mM dithiothreitol) three times, followed by elution o f the bound proteins by boiling in
2X SDS-PAGE sample buffer. To minimize the elution of heavy or light antibody chains
from the beads, 0.1 M glycine buffer pH 3 was also used to elute proteins from the beads.
To examine the binding o f recombinant 5 to PDE by immunoprecipitation, 5 was
added to ROS and incubated overnight to release PDE from the membrane. The
supernatant was collected and incubated with ROS1 coupled to Sulfolink beads for at
least 2 hours at 4° prior to washing and eluting the proteins bound to the beads.
Alternatively, PDE binding to recombinant GST-5 and its release from its membraneattached state was assayed by using glutathione-agarose beads to pull down GST-5 and
any proteins to which it was bound.
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Gel filtration chromatography o f hypotonic extracts o ffro g ROS- Hypotonically
extracted PDE was chromatographed on a Superdex 200 (Amersham Pharmacia Biotech)
column equilibrated in: 5 m M Tris (pH 8), 0.5 mM EDTA, 10 mM NaCl, 1 mM
dithiothrietol, 0.2 mM Pefabloc. 0.3 ml fractions were collected. PDE elution was
determined by an activity assay. The protein-containing fractions were precipitated with
3.5% TCA, incubated for 5 minutes at room temperature, and then centrifuged. The
pellets were resuspended in Laemmli gel sample buffer and heated to 80° for 10 minutes.
The proteins in the fractions were examined by western analysis. A standard curve for
the molecular weight calibration o f the Superdex 200 was done using the Molecular
Weight Marker Kit for gel filtration chromatography range 29,000-700,000 (Sigma).

Results and Discussion
Frog retina contains a 17 kDa protein homologous to the bovine rod
photoreceptor 5 protein. To identify the frog retinal homologue o f the mammalian 17
kDa 6 protein, a Rana pipiens retinal cDNA library was screened using the bovine 5
nucleotide sequence as a probe. A clone containing the complete coding region (450
base-pairs) o f frog 8 was identified and sequenced. The deduced amino acid sequence for
frog 8 represents a protein o f 149 amino acids, one shorter than mammalian 8 (Figure
3.1). The amino acid sequence of frog 8 is 80% identical (90% similarity) to known
mammalian 8 sequences, indicating that this protein is highly conserved through
vertebrate evolution. Substantial sequence homology (60-70% sequence
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Figure 3.1. The frog 5 sequence is homologous to other 5 proteins. The deduced amino
acid sequence o f frog 5 was obtained from the nucleotide sequence (deposition Genbank
AY044177). Multiple sequence alignment with known 5 and S-Iike proteins was
performed using CLUSTALW (default options). The following 5 sequences were
aligned for evaluation o f the conserved amino acid residues: human 8, Q43924; mouse 8,
AAC40094; dog 8, AAD54058; bovine 8, Q95142; C. elegans 8, Q18268; D.
melanogaster 8, AC015134; chicken 8, derived from EST AL588430, and Ciona
intestinalis 8, AB079881. The consensus sequence for unci 19/RG4 was obtained from
analysis o f 8 sequences currently available in GenBank. The RhoGDI sequence is
GDIR_HUMAN, and the residues forming the prenyl binding pocket (Hoffinan et al.,
2000) are indicated with *.

identity) o f frog 8 with three invertebrate orthologues o f 8 is also evident when these
sequences are aligned (Figure 3.1). Phylogenetic analysis indicates that sequence
divergence of 8 agrees with the order of general evolutionary divergence, where
amphibians diverged earlier in time than mammals and birds.
Other proteins closely related to 8 have been identified, namely unci 19/RG4
(Higashide et al., 1996) and RhoGDI (Nancy et al., 2002). Based on comparisons o f the
predicted secondary structure and the pattern o f hydrophobic residues in the three
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proteins, a structural homology model based on the isoprenyl binding domain o f RhoGDI
has been proposed (Nancy et al., 2002). This prenyl binding pocket consists of all but the
extreme N-terminus o f 5, whereas the larger unci 19/RG4 and RhoGDI proteins
incorporate this dom ain in their C-terminal region. Figure 3.1 also include the consensus
sequence for unci 19/RG4 derived from alignment o f 8 sequences available in GenBank,
as well as the sequence for human RhoGDI.
Several residues o f the RhoGDI prenyl binding pocket are conserved in the 6
protein sequence. Thus, secondary structural information o f the 8 protein can be inferred
by comparison to the RhoGDI crystal structure analysis (Hoffinan et al., 2000). It was
proposed that the 8 protein folds similar to the C-terminal immunoglobulin-like domain
o f RhoGDI, creating a hydrophobic pocket. In RhoGDI, this pocket is where the
geranylgeranyl m oiety o f the small GDI protein inserts. The existence o f this pocket in
the 8 protein is consistent with several results (Marzesco et al., 1998; Linari et al., 1999b;
Linari et al., 1999b), including the ability o f 8 to release membrane-bound PDE (Florio et
al., 1996). However, 8 interaction with non-prenylated proteins such as the retinitis
pigmentosa GTPase regulator, RPGR (Linari et al., 1999b) and the Arf-like protein Arl3
(Linari et al., 1999a) that are localized to various tissues, may occur through a region
(amino acids 44-52) that is not conserved in RhoGDI (Nancy et al., 2002).
The majority o f the 8 sequence is involved in forming the isoprenyl binding
domain. U nci 19/RG4 is a 25 kDa protein that also contains sequence similarity in the
isoprenyl binding domain. Thus, these three proteins RhoGDI, U nci 19/RG4, and 8 m ay
form a family o f proteins whose role includes membrane trafficking o f proteins through
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interactions at this isoprenyl binding domain. The short sequence o f 5 suggests that it
may be the basic prototype for this family.

Recombinant fr o g 5 binds to and releases fro g PDE from ROS membranes. To
test whether frog 5 retains the biological activity reported for the mammalian homologue,
we expressed recombinant frog 8 in E. coli as a GST-fiision protein. Purification o f the
fusion protein by glutathione-agarose affinity chromatography yielded 4 mg o f GST-5
per liter o f bacterial culture. The apparent molecular weight o f the GST-5 was 43 kDa,
running as a single band on SDS-PAGE. After cleavage o f the GST portion with
thrombin and re-purification, the resulting 17 kDa 5 was >95% pure, and migrated
identically to native frog 8 on SDS-PAGE.
To test whether frog 5 retained the ability to solubilize membrane-bound PDE, we
added increasing amounts o f recombinant frog 5 to ROS homogenates. The soluble
proteins were separated from the membranes by centrifugation. In contrast to bovine
ROS where 20-30% o f the total PDE is found in the soluble fraction (Gillespie et al.,
1989), purified frog ROS have essentially no PDE in the soluble fraction (1.0 %± 0.2 %;
n = 5). Addition o f increasing amounts of frog 5 can release up to 100% o f the PDE from
ROS membranes in a dose-dependent maimer (Figure 3.2). The effectiveness with which
frog 8 releases frog PDE from the disk membrane is comparable to previously reported
values for bovine PDE solubilization (Florio et al., 1996). In both cases, a 4-6-fold excess
o f 5 relative to PDE is needed to solubilize 50% o f the total enzyme. The IC5 0 o f frog
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Figure 3.2. Frog 5 releases PDE from ROS membranes. Frog ROS homogenates (20-40
nM PDE) were incubated with increasing amounts o f recombinant frog 6 overnight at 4°.
Samples were centrifuged to separate solubilized (•) from membrane-associated (o) PDE.
The amount o f PDE in each sample was determined by the cGMP binding stoichiometry
(see Methods). Data are mean ± S.E.M. for 6 separate experiments.

PDE release from ROS membranes is 128 ±11 nM recombinant frog 5 (20-40 nM PDE,
4°). The time needed for 5 to exert its solubilizing effect on membrane-bound PDE is
slow: only one-third o f the total PDE is released after 5 h incubation of 5 with ROS at
4°, compared to 100% release after 24 h. The slow release o f membrane-associated PDE
by 5 is not explained by a slow incorporation of 5 into ROS membranes, since
immunoblot analysis shows no increase in 17 kDa 5-immunoreactivity in ROS
membranes following addition o f exogenous 5. Thus, recombinant 5 does not bind to
ROS membranes but rather slowly exerts a direct effect on PDE to solubilize this
enzyme.
To test whether recombinant 8 remains bound to PDE following its release from
the disk membranes, 8-solubilized PDE was immunoprecipitated with the PDE catalytic
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Figure 3.3. Frog 5 binds to PDE upon releasing it from the disk membranes. Frog ROS
homogenates were incubated with either recombinant frog 8 or GST-5 overnight. PDE
that was solubilized by treatment with 8 8 per PDE was immunoprecipitated with ROS1agarose beads, while PDE incubated with 30 GST-5 per PDE was pulled down with
glutathione-agarose beads. The supernatants and pellets were analyzed after a brief spin.
The immunoblot was probed with antibodies to 5 (FD) and PDE (NC).

subunit antibody, ROS 1 (Hurwitz et al., 1985). All o f the solubilized PDE was pulled
down with the PDE antibody, along with recombinant 5 (Figure 3.3). In a sim ila r
experiment, we incubated frog ROS membranes with recombinant GST-5, which also
solubilizes PDE effectively. After adding glutathione-agarose beads to the soluble PDE,
we were able to co-precipitate PDE bound to the GST-5 (Figure 3.3). Thus, 8 does not
act catalytically to release PDE from the membrane-associated state, but rather remains in
a complex with PDE following solubilization.

Effects o f S o n cGMP binding and transducin activation o f fr o g PDE. Membraneassociated bovine PDE contains two high affinity cGMP binding sites in its GAF
domains, but one o f these sites does not exchange its bound cGMP with free cGMP.
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Addition o f exogenous 8 to bovine rod PDE converts this nonexchangeable cGMP
binding site to an exchangeable site, but the overall binding affinity for cGMP is
unaltered by 8 binding (Mou et al., 1999). In comparison, frog PDE also has two highaffinity noncatalytic cGMP binding sites, but both o f them readily exchange bound
cGMP (Cote et al., 1994). To examine the effects o f 8 on frog PDE GAF domains,
binding o f 1 pM [3H]cGMP was measured as a function o f the amount o f 5 added. No
increase in the exchange rate o f bound cGMP was observed following 8 addition.
However, addition o f recombinant 8 decreased by up to 25% the maximum binding o f
cGMP to the noncatalytic sites o f frog PDE (data not shown). An 8-fold excess o f 8
relative to PDE was needed to observe this 25% decrease in cGMP binding, consistent
with the efficacy o f 8 to solubilize frog PDE. Because o f the positive cooperativity
between cGMP binding and the Py subunit interaction with PDE, we next examined
whether 8 could influence Py affinity for PDE. Addition o f increasing amounts o f 8 to
nonactivated PDE had minor effects on the basal rate o f PDE, suggesting little effect o f 8
on the interaction o f y with the catalytic sites. However, the ability o f 8 to affect cGMP
binding to frog and bovine PDE suggests that the mechanism o f 8 binding to the
isoprenylated C-terminus induces an allosteric change in the catalytic subunit that is
reflected in a local conformational change in the GAF domains. This significance o f this
effect is not clear at present.
A proposed role for 8 in phototransduction is to release PDE from the membrane,
preventing its association with transducin, thereby causing a decrease in the maximum
transducin activation o f PDE (Cook et al., 2001). To test the relevance o f this hypothesis
for frog ROS, nonactivated frog ROS homogenates were incubated overnight with
69
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recombinant 8, and then assayed for the maximal PDE activation by transducin. A
reduction in the maximum transducin-activated PDE rate correlated with the release o f
PDE from the membrane into the supernatant (Figure 3.4). We found that there was a
70% decrease in the maximum transducin-activated PDE rate with the addition o f a large
molar excess o f 5. The IC 50 for suppression of transducin activation o f PDE was similar
to the IC5 0 for solubilization o f PDE (Figure 3.4). This uncoupling o f transducin
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Figure 3.4. 5 decreases the ability of transducin to fully activate PDE. Light-exposed
ROS homogenates (40 nM PDE) were incubated with increasing amounts o f
recombinant frog 5 overnight at 4°. GTPyS (12.8 pM) was added to one portion to
determine the maximum extent o f PDE activation (o). The remainder (lacking GTPyS)
was centrifuged to measure the extent o f PDE solubilization (•). Western analysis o f the
nonactivated PDE samples shows that while the PDE is solubilized from the membranes
by recombinant 5, Toe remains membrane-bound. The immunoblot was probed with a
mixture o f the PDE (NC) and transducin (T a) antibodies. Graph shows the average ±
SEM for 3 separate experiments.
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activation o f PDE by 5 is not accompanied by solubilization o f the transducin a subunit,
since immunoblots show no release o f T a upon 5 addition (Figure 3.4), in agreement
with previous results (Cook et al., 2001). We conclude that in order for there to be
efficient activation o f PDE, PDE must be attached to the membrane in proximity with the
membrane-associated transducin. These in vitro results are consistent with the hypothesis
that 5 could desensitize the phototransduction pathway by regulating the subcellular
localization o f PDE.

Sub-stoichiometric levels o f the 5protein are fo u n d in fr o g ROS. In order for 5 to
solubilize the entire pool o f PDE in the rod outer segment, 5 m ust be present in
stoichiometric amounts relative to PDE. This is because 5 remains in a complex with
PDE following solubilization (Figure 3.3). To determine the concentration o f 5 in ROS,
we performed immunoblot analysis using anti-6 antibodies. W hen frog retinal
homogenates, crude ROS preparations, or Percoll-purified ROS were separated by SDSPAGE, several 6-immunoreactive bands were detected on immunoblots, including the
expected 6 band at 17 kDa (Figure 3.5). In retinal homogenates and crude ROS, the most
abundant 5-immunoreactivity was seen with proteins o f 17 and 33 kDa, with additional
bands o f lower intensity. However, purification o f frog ROS on a Percoll gradient to
obtain osmotically intact outer segments removes the majority o f the 17 kDa
immunoreactivity. This suggests that most of the 8-immunoreactivity seen in retinal
homogenates and crude ROS is o f non-ROS origin.
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Figure 3.5. Little 5 co-purifies with intact frog ROS. Frog ROS were purified on a
Percoll gradient to examine the localization of the 17 kDa 5 protein. Samples (1 pmol
PDE per lane) tested were: R, retinal homogenate; C: crude ROS; H, purified ROS
homogenate. Soluble proteins (IS) were separated from ROS membranes (IM) by high
speed centrifugation in the light. The membranes were resuspended with 10 mM MgCfe
and re-centrifuged to obtain a supernatant (MS) portion. PDE was released by a
magnesium-free hypotonic solution (see Methods) and centrifuged to obtain a supernatant
(HS) and membrane (HM) fraction. The affinity purified FL 5 antibody was used for the
western analysis.

To quantify the amount of 5 present in ROS, we compared the amount o f 17 kDa
immunoreactivity in ROS samples to known amounts o f recombinant, purified frog 5
applied to the same gel. We found only 0.03 ± 0.005 mol 5 per mol PDE in purified frog
ROS (Table 3.1). In contrast, the unpurified retinal homogenate contains 0.62 ± 0.05 mol
5 per mol PDE. The small amount o f 5 detected in ROS suggests that most o f the 17 kDa
protein in the frog retina is expressed in other cells o f the retina or in a portion o f the
photoreceptor cell other than its outer segment.
Because >95% o f PDE from frog ROS is membrane-bound (Norton et al., 2000),
we next determined the subcellular localization of 5 by centrifugation. Fractionation o f
ROS homogenates in an isotonic medium demonstrates that most o f the 17 kDa 5 protein
is soluble (Figure 3.5, lane IS). The fact that most 5 is soluble, while PDE is membrane-
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associated, indicates that the low levels o f 8 present in intact frog ROS are not sufficient
to solubilize a significant portion of the PDE. Other 5-immunoreactive bands detected in
ROS homogenates were found to localize to either the isotonic soluble or membrane
fractions. A small amount of the 5 protein remains membrane-associated at all times
including when PDE is extracted with hypotonic buffer or 10 mM CHAPS. When large
amounts o f the hypotonic extract are examined by western analysis, 36 kDa and 90 kDa
8-immunoreactive proteins are seen (Figure 3.7B). However, a portion o f each o f these
proteins is not extracted and can be found in the membrane fraction following hypotonic
extraction.
We considered the possibility that different expression levels or sub-cellular
localization o f S might result from the light history o f the retinas prior to isolation. No
differences were observed in either the 8 content o f frog ROS or its subcellular
localization when comparing dark-adapted versus illuminated conditions or subjective
day versus subjective night conditions (data not shown).
These results with frog ROS led us to re-evaluate whether the concentration o f 5
in bovine ROS is similar to our results reported above. Quantitative immunoblot analysis
using recombinant bovine 8 standards on the same gel as bovine ROS samples reveal low
levels o f 8 in sucrose-purified bovine ROS from frozen retinas (Table 3.1; 0.05 ± 0.001
mol 8 per mol PDE; n = 3). Bovine retinal homogenates contain ~10 fold greater amounts
o f 8 (0.44 ± 0.044 mol 8 per mol PDE; n = 8), suggesting a non-ROS origin for much o f
the 17 kDa 8 protein in both amphibian and mammalian retinas. Overall, the number and
relative intensity o f 8-immunoreactive bands in bovine ROS are qualitatively similar to
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Table 3.1: Content o f 5 and PDE in purified ROS
Source and
% PDE
total [8]
% 8 soluble
purification
soluble
(8/PDE)
Fresh frog
>80%
1%
0.03 ± 0.005
ROS/Percoll
n=5
Frozen
25%
4%
0.05 ± 0.01
bovine
n=3
ROS/sucrose
Fresh bovine
67%
35%
0.07 ±0.001
ROS/sucrose
n=2
Fresh bovine
70%
30%
0.1 ±0.008
ROS/Ficoll
n=3

Table 3.1. Quantitation o f 5 in ROS. The amount o f 5 in purified bovine and frog ROS
was determined by western analysis. ROS samples were loaded on SDS-PAGE along
with known amounts o f 6. The samples were transferred to PVDF membrane for
immunoblot analysis (FL antibody 1:20,000). The amount o f 8 in each ROS sample was
determined by Quantiscan. Data represents mean ± S. E. M. for n determinations. The
concentration o f PDE was determined by cGMP binding for frog PDE, and by activity
measurements for bovine PDE.

those in frog ROS. (Unlike Figure 1A o f Cook et al. (Cook et al., 2000), we did not
observe these bands to be artifacts associated with the secondary antibody.)
The amount o f 5 found in our purified bovine ROS from frozen bovine retinas
was less than expected based on previously published results (Cook et al., 2000). To
examine whether the results we obtained were due to the fact that the retina’s were frozen
prior to purification o f the ROS, we obtained sucrose- and Ficoll-purified ROS from fresh
bovine retinas (a kind gift o f Dr. Paul Schnetkamp, University o f Calgary) (Schnetkamp,
1981). Table 3.1 shows that the freshly isolated bovine ROS contained slightly more 8
than found in the frozen ROS samples, possibly due to disruption o f photoreceptor cell
integrity upon freezing and thawing the retinas.

However, the overall amount o f 8 in

fresh bovine ROS is much lower than the amount o f PDE present, consistent with our
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original observations in both frog and bovine ROS. The subcellular location of the 5 in
fresh bovine ROS is also similar to the data obtained from frog ROS. The main
difference between the two species examined is the am ount o f soluble PDE from each
preparation. The results obtained here suggest that the amount o f membrane association
is not due to the 5 protein, since the ratio between 5 and PDE in both species are similar
and the effect seen by exogenous 5 also is consistent. It is possible that the PDE in
bovine ROS contain a higher level o f carboxymethylation than that in frog ROS. Cook et
al. (2000), show that PDE that is released by the 8 protein contains a higher level o f Cterminal carboxymethylation at the site o f prenylation.

Localization o f 8 in the retina by immunocytochemistry. Previous research
showed the localization o f the 8 protein in bovine retina exclusively to the rod outer
segment portion o f the retina (Florio et al., 1996). However, the antibody that was used
for the immunocytochemistry results was not the same one presented in the paper
showing 8 localization on immunoblots. Thus, it is possible that the
immunocytochemistry results reflect some 8 -im m u n o re a c tiv e proteins other than 8. The
relative lack o f 8 found in the outer segment of the frog and bovine retina convinced us to
reexamine the localization o f the 8 protein in the retina.
Figure 3.6A shows the results o f immunocytochemistry o f a bovine retina with
the FL 8 antibody (red) used throughout this chapter for immunoblot analysis and double
labeling with an antibody raised to red/green opsin antibody to which detects cone cells
(COS; green). The scattered immunoreactivity in the outer segment layer (OS) o f the
retina is consistent with cone cells than the more abundant rod cells. The yellow
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Figure 3.6. Localization o f the 8 protein in bovine retina. Fresh bovine eyes were hemisected, everted and fixed in 4% paraformaldehyde. The eyes were washed in phosphate
buffer, and incubated in buffered sucrose. Cryosections were performed, and the sections
treated with primary antibody. Panel A was probed with FL (5 antibody) and COS (cone
opsin antibody). Panel B was probed with COS. The secondary antibody used was
conjugated to a fluorescent marker. Pictures were taken on a confocal microscope. The
layers o f the retina are: outer segments (OS), inner segments (ISO, outer nuclear layer
(ONL), outer plexiform layer (OPL), inner nuclear layer (INL), inner pleform layer (IPL),
ganglion cell layer (GCL), and the neural fiber layer (NFL). This work was performed
by N. Vardi, University o f Pennsylvania.

fluorescence shows cells that contain both cone opsin and 8 protein. Figure 3.6B shows
immunoreactivity of the cone cells alone by probing with COS. Interestingly, there are
three other cell layers that show 8 immunoreactivity(red), the inner segments (IS), inner
nuclear layer (INL) and ganglion cell layer (GCL). The wide distribution o f 8 in various
retinal cells is consistent with the quantitative immunoblot analysis we presented above.
This suggests that the 8 we see in our frog ROS preparations could be a contaminant from
either cone cells, or possibly the inner segment of rod cells. However, this
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immunocytochemistry is a preliminary experiment and more needs to be done to examine
8 localization, including controls for nonspecific labeling and co-localization o f 8immunoreactivity with photoreceptor-specific antibodies. Specificity o f the antibody will
be examined by blocking the retina with recombinant 5 prior to the antibody incubation.
We also need to repeat the immunocytochemical localization of 5 in the frog retina to
ensure that the results for the two species are the same.

Co-purification o f 5-immunoreactive proteins with PDE in fro g ROS. There was
more 5 immunoreactivity seen in higher molecular weight proteins than with the 17 kDa
band in purified frog ROS (Figure 3.5). We therefore questioned whether PDE was
interacting with other 5-like proteins present in frog ROS. We started by examining
whether any 8-immunoreactive proteins co-purified with PDE when it is released from
the membrane by hypotonic extraction. Treating washed ROS membranes with a
hypotonic buffer extracts -60% o f the PDE, but the very small amount o f 17 kDa 5
remains membrane-associated under this condition (Figure 3.5). Detergent extraction of
washed ROS membranes with 10 mM CHAPS releases 90% of the PDE, but not 8 (data
not shown). However, a 36 kDa protein which is membrane-bound under isotonic
conditions can be co-extracted with PDE upon treatment o f ROS membranes with a
hypotonic buffer (Figure 3.5, HS). Immunoblots with other anti-8 antibodies were
consistent with the results in Figure 3.5 with the FL 8 antibody.
Due to the co-solubilization o f PDE and the 36 kDa 8-immunoreactive protein
observed in frog ROS, we sought to determine whether this protein binds to PDE. When
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Figure 3.7. PDE does not associate with the 36 kDa S-immunoreactive protein. Frog
PDE was hypotonically extracted from purified ROS (HS) and 29 pmol were loaded on a
gel filtration chromatography column. 0.3 ml fractions were collected and portions
assayed for PDE activity (panel A). The remainder was concentrated, proteins separated
by SDS-PAGE, and immunoblots probed with FL antibodies (panel B).

we hypotonically extracted PDE and the 36 kDa protein from ROS membranes, and
immunoprecipitated PDE with ROS 1-Sulfolink beads, PDE was quantitatively
precipitated while the 36 kDa protein remained in the supernatant (data not shown). To
further investigate whether a 8-immunoreactive protein was binding to PDE, gel filtration
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chromatography was performed using hypotonically extracted PDE. The fractions were
analyzed by a PDE activity assay to determine where the PDE eluted (Figure 3.7). The
apparent Mr for hypotonically extracted frog PDE on the Superdex 200 column was 410
kDa. This suggests that either PDE does not behave as a globular protein on the column,
or that the PDE holoenzyme (Mr 220,000) exists in a complex with other ROS proteins
under these conditions. The latter possibility is supported by Coomassie staining o f the
PDE peak revealing additional, unidentified proteins co-eluting with PDE (data not
shown). Most o f the 36 kDa 8-immunoreactivity eluted at ~60 kDa.
Gel filtration o f PDE solubilized from ROS membranes by exogenous 5 showed a
similar apparent molecular weight to that seen in Figure 3.7. The majority o f the 8 and
PDE co-eluted from the column, demonstrating that the PDE-8 interaction was o f
sufficient affinity to remain in a complex during gel filtration. In contrast, PDE released
from ROS membranes by trypsin proteolysis had an apparent Mr o f 196 kDa. The failure
to detect significant binding o f 8-immunoreactive proteins by either ROS 1
immunoprecipitation or gel filtration chromatography m akes it unlikely that PDE is
regulated by binding o f 8 or a 8-like protein to the C-terminal, isoprenylated catalytic
subunits o f PDE.

Conclusions
The results presented here suggest that 8 is not a subunit o f PDE due to its low
abundance and lack o f binding to PDE in rod photoreceptor cells. Preliminary evidence
from immunocytochemistry suggests that 8 may be localized to cone and other retinal
cells, but not the rod outer segments. The wide tissue distribution o f the 8 protein
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suggests a more wide-spread role as a prenyl binding protein, possibly directing
intracellular targeting o f prenylated proteins. 5 also interacts with non-prenylated
proteins (Linari et al., 1999b; Linari et al., 1999a), so additional contact sites besides the
prenyl binding pocket are likely. The PDZ recognition sequence at its extreme Cterminus also presents the possibility o f serving to dock prenylated proteins into signaling
complexes.
Our comparative analysis o f frog and bovine ROS samples suggests that the
presence and abundance o f 5 in amphibian and mammalian retina are similar, consisten
with the high degree o f conservation o f other phototransduction components. It is likely
that the designation o f the 5 protein as a subunit o f PDE was premature, and if it has a
role in visual transduction, it is likely to be limited to cone cells.
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CHAPTER 4
BINDING OF ROD OUTER SEGMENT PROTEINS TO
PHOSPHODIESTERASE: POTENTIAL ROLES IN REGULATING
VISUAL TRANSDUCTION
Summary
Phosphodiesterase (PDE) is the central enzyme o f visual transduction. Proteins
such as y, 5 and GARP have all been shown to bind to PDE, and besides the well-studied
y subunit, other proteins may also serve to regulate the enzyme in vivo. We found that
the interaction between y and Pa(3 is very strong, such that a fragment o f y remains bound
to trypsin-proteolyzed frog PDE after dilution and purification by gel filtration
chromatography. Limited trypsin proteolysis o f the y subunit at 0.02 nM PDE resulted in
a catalytic rate o f 7870 ± 1 5 0 mol cGMP/PDE/sec for frog PDE, about twice the
transducin-activated rate. Due to the fact that proteolysis could cause an increased rate o f
hydrolysis, a method to nonenzymatically remove y was developed. The rate by this
method was 7000 ± 1 8 0 mol cGMP/PDE/sec, demonstrating that trypsin did not
significantly alter the enzymatic properties o f PDE during limited proteolysis.
It has been proposed that phosphorylation o f the y subunit can regulate PDE
during phototransduction. To test this, we developed a method to extract and purify y
from rod outer segments. Cell homogenates incubated in 30% acetonitrile/0.1% TFA and
then heated to 75° for 5 minutes were able to release 100% o f y for subsequent analysis.
Solid phase purification on a Sep-Pak column eluted the y at 40% acetonitrile/0.1% TFA.
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Besides y, other proteins in ROS bind to PDE. Gel filtration chromatography o f
solubilized frog PDE showed co-elution o f a number o f different proteins with PDE,
suggesting that PDE m ay exist in a multi-protein signaling complex. Specific proteins
that eluted in the PDE-containing fractions ran at 74 kDa, 65 kDa, 55 kDa, 50 kDa, and
43 kDa.
One candidate protein that could serve as a scaffold to form protein complexes
with PDE is the 5 protein. Co-precipitation o f ROS extracts with immobilized 8 pulled
down PDE and several other proteins, providing support for the idea that PDE exists in a
multi-component signaling complex in ROS. One o f these proteins may also serve as a
direct target for 5 in ROS, since the large excess of PDE over 8 makes it unlikely that the
major function o f 8 is to directly regulate PDE.

Introduction
1. Mechanism o f transducin activation o f PDE
PDE is a heterotetramer composed o f two catalytic subunits, P a and Pp, as well
as two identical inhibitory subunits, y. In the dark-adapted state, y maintains PDE
inactivity by physically blocking the active site (Takemoto et al., 1993; Artemyev et al.,
1998). Upon light exposure, activated transducin (Ta-GTP) binds to y and P a p , pulling y
away from the catalytic site, allowing cGMP to enter and become hydrolyzed. The
stoichiometry o f T a binding to PDE upon activation is controversial. It was widely
accepted that there were two binding sites for T a on PDE (Clerc and Bennett, 1992;
Pages et al., 1993). However, in order to obtain complete activation o f PDE, a large
excess o f Ta-G TP must be added for reconstituted systems, or activated for ROS
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membrane experiments (Wensel and Stryer, 1986; Bennett and Clerc, 1989; Malinski and
Wensel, 1992). This suggests that there could be a heterogeneity in the T a activation of
PDE, possibly due to the membrane binding o f T a as this is correlated to activation
(Fung and Nash, 1983; Melia et al., 2000). The large excess o f T a necessary to obtain
complete activation has made it difficult to determine both the stoichiometry o f T a
binding to PDE, as well as the stoichiometry o f T a required for complete activation o f
PDE. One possibility is that there is cooperative binding o f two T a to PDE for full
activation o f PDE (Whalen and Bitensky, 1989; Bruckert et al., 1994). It is also possible
that full activation o f PDE requires only one Ta-GTP and the second PDE catalytic site
remains inactive. Melia et al. (Melia et al., 2000) showed that complete activation o f
bovine PDE in reconstituted membranes occurs upon stoichiometric levels o f T a and
PDE.
In order to understand the activation of PDE by transducin, we first must have a
complete understanding o f the behavior of the catalytic dimer (PaP) lacking the
inhibitory y subunits. Limited trypsin proteolysis o f the y subunits will be examined, but
there is a concern that the proteolysis could alter the catalytic or regulatory properties o f
Pap (Hurley and Stryer, 1982). Thus, these results will be compared to PaP prepared
nonenzymatically, although there are limitations to this approach since previous attempts
have not released all o f the y (Yamazaki et al., 1990). The high affinity interaction
between y and PaP has made it difficult to get a complete characterization o f the catalytic
dimer Pap, as well as an accurate measurement for the binding affinity o f y for PaP
(Yamazaki et al., 1990; Yamazaki et al., 1996b; Arshavsky et al., 1992). Indeed, there is
some question as to whether or not y is released from mammalian PDE, or whether it is
83

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

simply displaced from the active site o f Pap (Whalen and Bitensky, 1989; Whalen et al.,
1990).
2. Extracting y from cell extracts to evaluate the significance o f post-translational
modifications o f y
Based on sequence analysis o f y, it has been proposed that phosphorylation or ADPribosylation o f the inhibitory y subunit may regulate the activity o f PDE in vivo. Visual
transduction is a highly regulated process, and these reversible modifications could occur
during times o f adaptation when the rod cell is completely saturated or exposed to a low
level o f background light.
To address the physiological significance of post-translational modification o f the y
subunit, we had to extract the y from purified ROS for chemical analysis. Previous
approaches to extracting y from purified mammalian PDE or from bovine ROS
membranes used heat, acetic acid, or a combination o f heat and formic acid to release y
(Hurley and Stryer, 1982; Wensel and Stryer, 1986; Hayashi et al., 1991). To extract y
from illuminated amphibian ROS homogenates, washes with GTP were done to release
Ta-G TP in a complex with y, followed by reverse-phase HPLC to purify the y (Yamazaki
et al., 1980; Yamazaki et al., 1983; Yamazaki et al., 1990). For the purpose of exam ining
light-induced modification o f the y subunit, methods to extract the y directly from darkadapted frog ROS had to be developed. There are many proteins that are soluble in frog
ROS, and others that may be released under the conditions o f y extraction. Thus, it would
be helpful to enrich for y prior to MS-fingerprinting. One common method that is used to
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further purify and concentrate proteins is to use a solid phase matrix. It is also easily
combined with reverse-phase HPLC which can further purify the desired protein.

3. Identifying proteins which associate with PDE to form a signaling complex
The y subunit is not the only protein believed to regulate PDE. Photoreceptor
PDE is unique in having C-terminal isoprenyl modifications that bind it to the disk
membranes. P a contains a famesyl group while Pp has a geranylgeranyl group (Anant et
al., 1992). This membrane association makes it difficult to determine proteins that bind
to PDE. Previous research has examined the role o f some key PDE-binding proteins and
the situations under which they bind to PDE. It has been found that T a in its non
activated state is capable o f binding to PDE, although with lower affinity (Gray-Keller et
al., 1990; Kutuzov and Pfister, 1994). It is possible that PDE exists in a complex with
several proteins, allowing for an accelerated response to light activation. Indeed, the
interaction o f PDE with several proteins may be dependent on light exposure (Maftei et
al., 2000). For example, GARP2 (glutamic acid-rich protein) is believed to bind to PDE
during bleaching adaptation, to prevent cGMP hydrolysis when the rod cells are
completely saturated (Korschen et al., 1999).
There are several different ways to characterize PDE binding proteins. Extraction
o f PDE from the membranes could disrupt protein-protein interactions under some
conditions, so a comparison o f several methods should be examined. PDE can be
released from ROS membranes using a hypotonic buffer (Emeis et al., 1982), or with 10
mM CHAPS detergent (Maftei, 2000). An alternate way to release PDE from the
membrane is to incubate overnight with a 15-fold excess o f 5 protein over PDE (Norton
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and Cote, 2001). Varying the method o f extraction (hypotonic, detergent, or 5 protein)
will help identify artifacts that might occur with any one extraction method. Alternate
methods o f PDE purification should also be examined. Immunoprecipitation, gel
filtration, and pull-down assays can all be used for separating PDE from proteins that are
in solution but not associated with PDE. Once proteins have been identified by protein
staining, they can be characterized by western analysis or by mass spectroscopy.

4. Investigation o f 5 binding proteins in ROS
In mammalian retinas, -30% o f the PDE exists in a soluble form bound to a
protein called 5 (Gillespie et al., 1989; Florio et al., 1996). It is believed that 5 binds to
PDE at its C-terminus, releasing it from the disk membranes of the rod outer segment
where transducin is localized, and preventing the enzyme from being activated upon light
exposure (Cook et al., 2000; Cook et al., 2001; Norton and Cote, 2001). Recently,
several published studies have proposed that 5 may play a general role in signal
transduction due to its wide tissue distribution (Florio et al., 1996; Marzesco et al., 1998).
The majority o f 6 expression is found in the retina, but its presence in the brain and
adrenal glands suggests that the role of the 5 protein exists in all nerve cells, and not
specifically as a regulator o f PDE in photoreceptor cells (Florio et al., 1996). The Cterminus o f the 5 protein encodes for a putative PDZ binding domain (Marzesco et al.,
1998) which could bind to many different proteins. PDZ-containing proteins are often
located to microdomains on a specific plasma membrane (Marzesco et al., 1998). It was
found that deletion o f the PDZ domain o f 5 destroys the membrane localization o f 8 in
epithelial cells (Marzesco et al., 1998).
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Alignment o f the 5 sequence with RhoGDI, a protein involved in regulating
membrane association o f Rho and Rab GTPases (Hoffman et al., 2000), shows 24%
sequence identity in the known prenyl binding domain (Nancy et al., 2002). This is
consistent with the observation o f that 5 has been shown to solubilize Rab 13, a
geranylgeranylated Ras-related protein, in addition to Pa(3 (Marzesco et al., 1998). The
ability o f 8 to solubilize RPGR (Linari et al., 1999b) and Arl3 (Linari et al., 1999a), two
non-prenylated proteins, could occur through the PDZ-binding domain o f 8 or possibly in
a region o f 8 that diverges significantly from RhoGDI (Marzesco et al., 1998; Nancy et
al., 2002). The large variety of proteins that bind to 8 also suggest that 8 may play a role
in scaffolding by allowing proteins to come together as a complex.
Chapter 4 addresses the regulation o f PDE by PDE-binding proteins, with a strong
focus on the y subunit. Several experimental results encouraged us that further analysis
was necessary to fully understand the interaction o f y with Pa|3. First o f all, the literature
contained no convincing measurements for the maximum catalytic activity of frog rod
P a p and whether the activity of transducin and trypsin activated PDE are equal. Our
results demonstrate that one of the y subunits is not displaced from the catalytic site upon
transducin activation o f frog PDE. Second, in pilot experiments to investigate the
phosphorylation o f y we developed a method by which in vivo levels o f Py
phosphorylation could be measured. Third, we carried out preliminary experiments to
identify possible regulatory interactions of PDE with other proteins using gel filtration
chromatography. Finally, to examine the potential role o f 8 in rod photoreceptors, the
chapter concludes with studies o f 8 binding proteins that are present in ROS.
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Materials and Methods

Materials. Frogs (Rana catesbeiana) were purchased from Niles Biologicals.
Membranes for filter binding assays were obtained from Millipore. [3H]cGMP was
purchased from PerkinElmer Life Sciences. Immunoblotting reagents, substrates and
nitrocellulose and PVDF membranes were purchased from Pierce or BioRad. All other
chemicals were obtained from Sigma.

Preparation o f purified rod outer segments (ROS). Rana catesbeiana were decapitated in
the dark and the eyes were dissected under infrared light. The retinas were removed and
osmotically intact ROS were purified on a discontinuous Percoll density gradient as
previously reported (Cote, 2000). The cells were homogenized with a mortar and pestle
at 4° (Dumke et al., 1994). Pseudointracellular medium (LIM) was used for most cell
preparations: 77 mM KC1, 35 mM NaCl, 2.0 mM MgCl2, 1.0 mM CaCl2, 10 mM HEPES
(pH 7.5), 2 mM dithiothreitol, 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 5 pM
leupeptin, and 1 pg/ml pepstatin. The concentration o f rhodopsin was measured by
difference spectroscopy (Bownds et al., 1971). An alternative buffer was used when PDE
activity measurements were done (see below). Endogenous nucleotides were eliminated
by incubation o f the homogenized ROS in the dark for 30 minutes at room temperature.
The amount o f PDE in the sample was determined by a cGMP binding assay (see below).
Bovine ROS from frozen retinas were purified under infrared light on a
discontinuous sucrose gradient (McDowell, 1993). ROS were homogenized at 4° in an
isotonic medium (25 mM Tris pH 7.5, 30 mM NaCl, 60 mM KC1, 2 mM MgCl2, 1 mM
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DTT, mammalian protease inhibitor cocktail) . The amount o f PDE was determined by
an activity assay.

Preparation o f recombinant y. Bovine recombinant y was expressed in Escherichia coli
and purified as previously reported (Granovsky et al., 2000). The final purity o f the y
protein was found to be >97% by Coomassie staining on acrylamide gels. The
concentration o f the y subunit was determined by spectroscopy and correlated with its
ability to inhibit trypsinized PDE activity upon addition o f 2 mol y per mol PDE (Cote,
2000). The activity assays and spectroscopy results agreed to within 10% for all o f the
experiments in these studies.

Preparation o f recombinant fro g GST-8. Recombinant frog 5 was prepared as described
in the Methods section o f Chapter 3. The protein was produced in E. coli as a GSTfixsion protein. The GST was removed from 8 using a thrombin cleavage kit, followed by
purification on a glutathione column. The final sample was concentrated by
ultrafiltration and stored in 50% glycerol at -20°.

PDE activity assays. The amount o f cGMP hydrolyzed by trypsinized, transducinactivated, and y-depleted P ap was measured by a phosphate release assay as previously
described (Cote, 2000). The buffer used for this assay (TEM) contained: 20 mM Tris
(pH 7.5), 10 mM M gCb, 0.5 mg/ml bovine serum albumin. The assay was done in a 96
well plate by addition o f 10 mM cGMP to the activated PDE-containing samples. The
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measurements were taken at a time when less than 30% o f the total cGMP was
consumed.

cGMP binding assays. PDE binds cGMP with high affinity to two noncatalytic cGMP
binding sites. Since it is the only photoreceptor protein to bind cGMP with high affinity,
measurements o f [3H]cGMP binding to frog PDE allow estimates o f the active PDE
concentration (Cote, 2000). 1 pM [3H]cGMP was added to PDE preparations in the
presence o f 200 pM zaprinast (to prevent cGMP hydrolysis) and incubated for 10 min at
room temperature. 10 pi portions were then filtered through a pre-wet 0.45 pm
nitrocellulose filter and washed with ice-cold pseudointracellular medium. Filters were
shaken in scintillation fluid (Ultima Gold) for 20 minutes and radioactivity was measured
in a Packard scintillation counter.

Gel filtration o ffro g PDE. Purified frog ROS homogenates were pelleted by
centrifugation (3 minutes; 110,000 gaV)- Isotonic soluble proteins were removed and the
pellet was washed in hypotonic buffer containing 10 mM MgCl2 (Hypotonic buffer: 5
mM Tris-HCl (pH 8), 0.5 mM ethylenediamine-tetraacetic acid, 1.0 mM dithiothreitol,
and mammalian protease inhibitor cocktail) to remove any rem aining soluble proteins.
The membranes were then extracted three consecutive times with hypotonic buffer
lacking Mg2+ to release PDE from the membranes. The first extraction included a 10
minute incubation on ice prior to pelleting the membranes. The concentration o f PDE in
the hypotonic extract was determined by cGMP binding and cGMP hydrolysis. The
PDE-containing extract was then chromatographed on a Superdex 200 gel filtration
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column at 0.5 ml/min equilibrated in 5 mM Tris-HCl (pH 8), 0.5 mM ethylenediaminetetraacetic acid, 10 m M NaCl, 1 mM DTT and mammalian protease inhibitor cocktail.
0.3 ml fractions were collected for analysis. PDE-containing fractions were determined
by measuring cGMP hydrolysis o f a portion o f the fraction that had been exposed to
trypsin on ice for 10 minutes. To concentrate the proteins in the fraction, the desired
fractions were precipitated with 3.5% TCA. The TCA was added for 5 minutes at room
temperature then centrifuged (3 min at 12,000 rpm) to pellet precipitated proteins. The
supernatant was removed and the pellet resuspended in gel sample buffer. The samples
were neutralized using 1 M Tris-HCl (pH 8).

Preparation o f Pa/3. For these experiments, P a p was made by trypsin proteolysis or by
nonenzymatic removal o f the inhibitory y subunits. For trypsin proteolysis, a time course
o f trypsin addition w as used to determine the amount of trypsin and the length o f time o f
proteolysis needed for each preparation (Figure 4.1). PDE was added to TEM buffer and
incubated on ice. Trypsin was added, the sample was mixed and remained on ice
throughout proteolysis. The trypsin proteolysis was quenched by the addition o f soybean
trypsin inhibitor, either by addition o f a small amount o f the PDE to the trypsin inhibitor,
or by adding a 6-fold excess (compared to trypsin amount) to a large amount o f
trypsinized PDE. The samples were then brought to room temperature prior to cGMP
addition. To ensure accurate results, three time points of cGMP hydrolysis were
measured for each o f the trypsinized PDE samples.
For non-enzymatic preparations o f P a p , several different methods were examined
for their ability to release y from P ap (See Results, Table 4.1). Purified, nucleotide-

91

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

10
CO

8

c

6

CO
CO

4

2

0
CD

0

10

30
20
Tim e of trypsinization (min)

40

Figure 4.1. Time course o f frog PDE trypsinization. Trypsin (50 pg/ml) was added to
purified frog ROS (114.1 nM PDE) on ice. Trypsin activity was quenched by additing 10
p.1 PDE into 90 p.1 o f soybean trypsin inhibitor (50 (j.g/ml). Samples were diluted with
TEM and brought to room temperature. cGMP was added and three time points were
taken for each o f the different trypsin proteolysis lengths. The rate values plotted
correspond to the linear regression o f the cGMP incubation time points. V ^ x for the
experiment was 4770 cGMP/PDE/sec ([PDEfinai] = 10.3 nM).

depleted frog ROS were exposed to light in LIM. GTPyS was added for a 1 hour
incubation at 4° to allow y to be released from P a p . Membranes were pelleted in the
centrifuge at 110,000 x gaV. The supernatant was discarded, and the process was repeated
to release more y from P ap . The amount of y remaining on PDE was determined by its
ability to bind [3H]cGMP, since the P a p lacking y do not bind cGMP in the noncatalytic
sites. The total concentration o f PDE in the sample was determined by measuring
[3H]cGMP binding in the presence o f a molar excess o f recombinant y.
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Purification o f y using the Sep-Pak column. The cartridge was solvated in 10 ml o f
acetonitrile, then flushed with 10 ml o f 10 mM Tris, pH 7.5. Next, the y-containing
sample was loaded on the cartridge and washed with 5 ml of 10 mM Tris. The y was
eluted with 0.2 ml fractions o f the following solvents: 10 % acetonitrile/0/1% TFA, 40%
acetonitrile/0.1% TFA, and 100% acetonitrile/0.1% TFA. This procedure was routinely
used in the lab for purification o f y. The amount o f y recovered from the column was
determined by spectrophotometry (OD 2 7 7 ) or by its ability to inhibit trypsinized PDE.

Pull-down assay o f proteins binding to immobilized 5. To measure the binding o f ROS
proteins to S, two similar methods were used to immobilize 5 to beads. In the first
approach, 67 pg o f GST-5 was added to 20 pi o f glutathione-agarose beads. The sample
mixed at 4° for 1.5 hours before centrifuging the beads (5 min. at 12,000 rpm). The
beads were washed with TMN buffer (TMN buffer: 50 mM Tris pH 7.5, 0.1 M NaCl, 0.5
mM MgCl2 ) prior to the addition o f ROS extracts (extracted using 10 mM CHAPS or
hypotonic buffer). After incubating at 4°, samples were centrifuged and the supernatants
were collected (unbound fraction). The beads were washed with TMN buffer three times
and then the 5-binding proteins were eluted with 10 mM reduced glutathione in 10 mM
Tris (pH 8). The samples were TCA precipitated, resuspended in Laemmli gel sample
buffer, neutralized, and heated to 80° for 10 minutes prior to being analyzed by SDSPAGE. Any proteins remaining on the beads were collected by adding Laemmli SDSPAGE gel sample buffer and heating the sample to 80° for 10 minutes. The specificity o f
protein binding to immobilized 5 protein was determined in two ways. First, ROS
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extracts were incubated with beads lacking bound 8. Second, an excess o f GST-8 was
added to the ROS sample during the incubation to compete with the 8-beads.
A second set o f experiments utilized 8 covalently coupled to beads. 8 (cleaved
from its fusion partner by thrombin proteolysis) was coupled to CNBr-activated beads
following the manufacturer’s instructions. Untreated sites were blocked by incubating
the beads with 0.1 M ethanolamine for an hour at room temperature. The beads were
then washed and stored in 0.02% sodium azide. These beads were then used in the same
manner as described above to pull down 8 binding proteins form ROS extracts. To
eliminate nonspecific binding of proteins to the S-beads more completely, 0.1% Triton X100 was added to the sample during incubation and to the wash buffer (wash buffer: 50
mM Tris-HCl pH 8, 0.1% Triton X-100, 0.5 M NaCl).
For experiments testing bovine ROS extracts, bovine PDE was hypotonically
extracted from purified ROS membranes as described above for frog PDE hypotonic
extraction. Detergent extraction of PDE resulted from addition o f 10 mM CHAPS to
resuspended bovine ROS membranes in isotonic buffer. This was repeated 3 times and
the extracts from each were pooled together as one sample.

Results and Discussion

The conditions o f trypsin proteolysis o f y greatly affects the maximum PDE activity. To
better understand y binding to Pap, the catalytic dimer itself must be studied. One
common method for preparing PaP is by trypsin proteolysis o f the enzyme (Hurley and
Stryer, 1982). When the PDE holoenzyme (PaPyy) is exposed to trypsin, the y subunits
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are cleaved (PaP) and the C-terminus o f PDE is also cleaved, causing PDE to be released
from the disk membrane (Oppert et al., 1991; Catty et al., 1992). The maximum rate
measurements for trypsin-activated PDE4were found be greater than for transducin
activation (Norton et al., 2000). There is wide variation in the literature for the kat value
for trypsinized and transducin-activated PDE, although generally trypsin activates PDE to
a greater extent than transducin activation (Pugh, Jr. and Lamb, 1993).
While examining trypsin proteolysis o f PDE (tPDE) as a method o f preparing
P aP , we found that the concentration o f PDE at the time o f the trypsin proteolysis greatly
affected the activity o f the enzyme, such that the lower the concentration o f the PDE at
the time o f trypsinization, the higher the maximal catalytic activity. However, if the PDE
was trypsinized at a high concentration (>100 nM PDE) and subsequently diluted prior to
assaying the activity, an increase in maximum activity was also seen (Figure 4.2). The
fact that the proteolysis and assay conditions alter the catalytic rate obtained may account
for the variation seen in the literature for the maximum catalytic rate o f trypsinized frog
PDE (Whalen and Bitensky, 1989; Whalen et al., 1990; Yamazaki et al., 1996a;
D'Amours and Cote, 1999). Interestingly, the maximum activity observed by
trypsinization was about 7500 cGMP/PDE/sec. The maximum kat for transducinactivated PDE (taPDE) was found to be 4400 cGMP/PDE/sec (D'Amours and Cote,
1999; Norton et al., 2000).
These differing values for the maximal rate o f tPDE and taPDE could arise from a
number o f different circumstances. First, it could be that transducin is only activating
one o f the two catalytic sites on PDE. However, trypsinization o f PDE should result in a
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Figure 4.2. Dilution o f trypsinized PDE gives a higher maximum catalytic activity. Frog
ROS homogenates (120 nM PDE) were trypsinized on ice with 0.2 mg/ml trypsin for 10
minutes. The reaction was quenched with 1.25 mg/ml STI. The trypsinized PDE was
diluted to the indicated concentrations. Three time points o f cGMP incubation were used
to obtain the P ap rate measurements. This graph is representative o f 2 separate
experiments.

kcat exactly twice the kcat of taPDE, which is not the case. It is possible that transducin
activation o f PDE completely activates one catalytic site, and slightly (10-20%) activates
the second site.
An alternate scenario could be that Ta-GTP activates each catalytic site equally,
but not to 100%. This would result in any ratio o f activation by transducin, including a
maximal observed rate of 60% the tPDE kcat- Thus, equal activation o f each catalytic site
agrees with the results we obtained.
Alternatively, negative cooperativity could also account for the result, if
activation at one site makes activation o f the second site less likely. We also cannot rule
out from our studies the presence o f diverse populations of PDE (Pap, P aa, PPP). This

96

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

scenario could provide the exact maximum rates we found, with each population
contributing differently to the final value.
One hypothesis is that the maximum rate for trypsin-proteolyzed PDE should be
8800 cGMP/PDE/sec, and that not all o f the y inhibition was abolished. Figure 4.1 shows
that the PDE has been trypsinized to its maximal activity. However, it is possible that a
fragment o f the y subunit remains after trypsin proteolysis o f PDE that would inhibit
catalysis to some extent. Analysis o f the trypsin cleavage sites (using Protein Parameters
in EXPASY) predicts that a fragment (aa 45/46-87) containing the inhibitory C-terminus
is formed. To test this, the different samples o f diluted tPDE used in Figure 4.2 were
subsequently transducin activated by addition o f GTPyS, but no further increase in
activity was seen. However, results presented in Chapter 3 would suggest that PDE
released from the membrane upon trypsinization removes it from the vicinity of T aGTP.
The C-terminus o f y is the primary region involved in inhibition o f cGMP
catalysis. Addition o f a y antibody to the C-terminal region o f y might be expected to
compete with PaP for y binding and subsequently activate the enzyme. However, when
trypsinized PDE was incubated with an excess o f C-terminal y antibody, no increase in
tPDE activity was observed (data not shown).

Upon trypsinization, fro g PDE retains a fragm ent o f ythat is not removed by dilution o f
the sample. To examine whether there was truly a tryptic fragment (specifically 45/4687) o f y that did not dissociate from P a p upon trypsin proteolysis, we tried purifying the
trypsinized PDE by ultrafiltration or gel filtration. Due to the results shown above
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(Figure 4.2), we suspected that the concentration o f the tPDE may alter the affinity o f the
y fragment for the P ap . Thus, two different concentrations were tested. Figure 4.3
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Figure 4.3. Trypsinized PDE binds a fragment o f y even after gel filtration
chromatography. Frog ROS homogenates at two different concentrations (concentrated:
100 nM PDE, A; and diluted 2 nM PDE, B) were trypsinized to 60% o f their maximum
activity. Membranes were removed by centrifugation (3 min, 110,000 x gaV). The
trypsinized PDE-containing supernatants were purified by gel filtration chromatography
on Superdex 200. PDE-containing fractions were pooled and concentrated by
ultrafiltration (Millipore Biomax 30K MWCO filter). Western analysis was done using
the antibody to the C-terminal region o f y (UNH-9710, 1:30,000).

shows that a 4.5 kDa fragment o f y was not completely removed upon gel filtration when
the sample was trypsinized at either a high concentration or a low PDE concentration.
Full length y is observed at —11 kDa on SDS-PAGE. Figure 4.3 shows a loss o f the 11
kDa band and an appearance o f a 4.5 kDa proteolytic band that co-elutes with PDE
catalytic subunits during gel filtration chromatography. If the y fragment had dissociated
from P aP , then it would have eluted from the Superdex 200 in the included volume for
this column (—25 ml), not at an apparent MW o f 300,000 kDa. The fragment was also
observed bound to tPDE when treated with two consecutive dilutions followed by
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ultrafiltration prior to gel filtration (data not shown). This method was used to increase
the likelihood that the low MW fragment would separate from Pa(3 and enter the filtrate,
while PaP would remain in the retentate. The co-purification o f PaP with the 4.5 kDa y
fragment under these conditions suggests that the fragment o f the y subunit remains
associated with P aP upon trypsinization, even at low PDE concentrations. Thus, this
fragment could be limiting the maximum activity o f the trypsinized PDE. Dilution o f the
sample to sub-nanomolar PDE concentrations may induce dissociation o f the 4.5 kDa
fragment, thereby further increasing the apparent kcat.

Developing alternative methods to prepare Paf3 lacking y. It is possible that the
higher catalytic activity o f trypsinized PDE compared to transducin activated PDE could
arise from a proteolytic artifact resulting from cleaving a portion o f P ap. Therefore, we
searched for an alternative method to remove the y subunits from the PDE holoenzyme.
Upon transducin activation, Ta-GTP binds to y and releases some o f it from its
association with PaP (Yamazaki et al., 1990). Yamazaki et al. (Yamazaki et al., 1996b)
found that the release o f y from Pap with Ta-GTP was higher in the presence o f salt.
Unfortunately, none o f the conditions we tested were able to remove all o f the y from
P ap. We found that the best method for preparing P ap was to centrifuge nucleotidedepleted frog ROS homogenates after two consecutive one-hour incubations in the
presence o f either GTPyS or GTP (Table 4.1). To compare the catalytic activity o f this ydepleted P aP to that o f trypsinized PDE, we determined the amount of y remaining on the
PaP using a cGMP binding assay (see Methods). PaP lacking y subunits cannot bind
cGMP with high affinity to the noncatalytic cGMP binding sites
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 4.1
Summary of PaP preparations
Concentration
of NaCl

pH

GTPyS

Number of
spins

200mM NaCl
300 mM NaCl
600 mM NaCl
300 mM NaCl
600 mM NaCl
300 mM NaCl
600 mM NaCl
600 mM NaCl
0

7.5
7.5
7.5
8.5
8.5
9.5
9.5
6.5
7.5

GTPyS = 2 x [rho]
0
0
0
0
0
0
0
GTPyS = 2 x [rho]

2
1
1
1
1
1
1
5
3

Amount of y
remaining (mol
y per mol PDE)
0.25
0.25
0.24
0.25
0.27
0.33
0.35
0.26
0.16

Table 4.1. Nonenzymatic preparation o f P a P . ROS homogenates were treated
with varying levels o f salt, pH and GTPyS to remove the y subunit o f PDE. The y was
removed by centrifugation for 3 min (110,000 gaV). The amount o f y remaining was
determined using a cGMP binding assay. Filter binding was done on the Pap sample
with and without recombinant y to indirectly estimate the amount o f y bound to the
depleted PaP samples.

(Arshavsky et al., 1992; Cote et al., 1994). Thus, the amount o f cGMP binding to ydepleted PaP represents a 1:1 relationship with the amount o f y remaining bound to Pap.
By comparing this value with the binding of the same PDE sample supplemented with
excess recombinant y, the amount of endogenous y still bound to PaP can be determined.
We then measured the maximal activity o f the PaP preparation and extrapolated
the value to determine the catalytic rate we would obtain i f no y was bound. By this
method, the kcat for PaP was estimated to be 7000 ± 180 cGMP/PDE/sec. The similarity
o f this result to the kcat obtained with trypsinized PDE demonstrates that trypsin
proteolysis o f PDE does not alter significantly the maximum catalytic activity o f the PaP
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dimer. Also it supports the hypothesis that transducin-activated PD E only activates PDE
to 50%-60% o f the maximum possible rate, most likely by activating primarily 1 active
site.
The fact that not all o f the y could be removed from the catalytic dimer suggests
that not all PaP molecules are behaving identically. PDE heterogeneity is also suggested
by the observation that only 60%-70% o f the total frog PDE can be released from the disk
membrane by hypotonic extraction. In an effort to discover whether the tight association
of y to P aP is related to the tight membrane association o f PDE, w e hypotonically
extracted our y-depleted P aP sample. We found that there was no direct correlation
between membrane association and y association o f PDE. Measurements o f the PaP
released from the disk membranes by hypotonic extraction showed that the released PDE
still contained the same ratio o f y to PaP as was seen prior to extraction (data not shown).
These observations were used as a basis for examining the activation o f frog PDE
by transducin, focusing specifically on the role o f the y subunit. The results o f this
detailed investigation are presented in Chapter 3 o f this thesis.

The y subunit o f PDE can be extracted from purified, intact fro g R O S fo r analysis ofposttranslational modifications. The tight association between P aP and y heightens the need
for understanding how this interaction is regulated in vivo. It has been suggested that
phosphorylation o f y plays a role in adaptation o f the cell by increasing or decreasing the
affinity o f y for either P aP or T a (Hayashi et al., 1991; Udovichenko et al., 1993; Xu et
al., 1998; Tsuboi et al., 1994; Matsuura et al., 2000; Hayashi et al., 2000). To examine
the occurrence o f post-translational modifications o f the y subunit in vivo, we developed a
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Figure 4.4. Extraction o f endogenous y from frog ROS. Frog ROS homogenates (0.2
nmol o f rhodopsin) were treated to remove soluble proteins. The ROS membrane pellets
were treated in the following ways: TEM+ (A), TEM+ boiled for 5 min (B), 10%
acetonitrile/0.1% TFA (C), 10% acetonitrile/0.1% TFA heated to 75° for 5 min. (D), 20%
acetonitrile/0.1% TFA (E), 20% acetonitrile/0.1% TFA heated to 75° for 5 min (F), 30%
acetonitrile/0.1% TFA (G), and 30% acetonitrile/0.1% TFA heated to 75° for 5 min (H).
The samples were spun in the Airfuge at 30 psi for 5 minutes as soon as possible.
Supernatants were collected and the pellets were resuspended in TEM+. The results were
analyzed by western analysis using the C-terminal y antibody.

method for quantitating and partially purifying y from ROS extracts. Several conditions
were tested and it was found that heating the sample for 5 minutes at 75° in 30%
acetonitrile/0.1% TFA released all o f the y from ROS homogenates (Figure 4.4). For
samples where we wanted to extract y from intact ROS, we obtained better recovery o f
endogenous y if the whole cells were first treated with acetonitrile, then sonicated or
disrupted by a freeze-thaw cycle prior to heating to 75°.
After extraction, the y was purified on a solid reverse phase C -l 8 Sep Pak
cartridge in order to avoid loading large amounts o f impurities from frog ROS extracts on
an HPLC column (see Methods). This method was first optimized using purified
recombinant y. Figure 4.5 shows the elution profile o f the recombinant y measured by
absorbance

(O D 2 7 7 )

as a function o f the acetonitrile concentration. Elution o f y from the
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Figure 4.5. Purification o f recombinant y on reverse phase Sep Pak cartridges. 27
pg o f recombinant bovine y was loaded on the Sep Pak cartridge (WAT023501)
equilibrated in 10 mM Tris, pH 7.5. The sample was washed with 10 mM Tris. The
sample was then eluted with 0.1 ml of each o f the following buffers: 10%
acetonitrile/0.1% TFA (fractions 1-5), 20% acetonitrile/0.1% TFA (fractions 6-9), 30%
acetonitrile/0.1% TFA (fractions 10-13), 40% acetonitrile/0.1% TFA (fractions 14-17),
and 50% acetonitrile/0.1% TFA (fractions 18-22). The elution o f y was measured by
absorbance (OD277), as well as by the ability o f the y to inhibit trypsinized PDE(not
shown).

Sep Pak cartridge occurred at 40% acetonitrile/0.1% TFA. Fraction 14 showing the
highest absorbance at 277 nm also had the greatest inhibitory potency for trypsinized
PDE. The amount recovered was 67% (18 pg) o f the y protein loaded on the column (27
Pg)Once this simple enrichment procedure for y was developed, ROS samples could
be tested under different illumination conditions to examine whether changes in y
phosphorylation serve as a regulatory mechanism o f visual transduction. These initial
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experiments were the basis for work performed by Michael Paglia in the lab (Paglia et al.,
2002 ).
Identifying novel PDE binding proteins. The y subunit is only one protein that binds to
PDE. Other proteins that are known to interact with PDE are transducin, GARP2 and 5.
However, understanding the role o f each o f these PDE-binding proteins, and when they
each may bind in vivo has not been well established. It is also likely that there are some
yet unidentified proteins that bind to PDE in vivo, possibly contributing to the regulation
o f visual transduction. We chose to analyze PDE solubilized from ROS membranes
using gel filtration chromatography.
Nonactivated PDE from frog ROS was hypotonically extracted from washed ROS
membranes. This extracted frog PDE was applied to a Superdex 200 gel filtration
chromatography column, and the PDE-containing fractions were identified by a cGMP
hydrolysis assay (Figure 4.6A). As seen in panel B o f Figure 4.6, the PDE-containing
fractions have other protein bands besides P a and Pp. Proteins o f lower molecular
weight that elute in these fractions must be in a protein complex or form oligomers.
Bands o f particular interest are those that appear solely in the fractions containing the
majority o f the PDE activity (fractions 30 and 31). A doublet arises at about 50 kDa
which is not seen on the gel prior to fraction 30. Other protein bands that could be
important are -7 4 , 65, 55, and 43 kDa. However, just because they elute at the same
molecular weight as PDE does not mean that they are bound to PDE, as they could be in
a completely different protein complex, or in association with another protein that
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Figure 4.6. Gel filtration o f hypotonically extracted proteins from frog ROS membranes.
9 pmol of hypotonically extracted frog PDE was run at 0.5 ml/min on a Superdex 200 gel
filtration column. 0.3 ml fractions were collected. A PDE activity assay was done to
measure the elution profile o f PDE from the column (panel A). The top axis shows the
corresponding molecular weight standards. The fractions were TCA precipitated,
suspended in gel sample buffer, and then run on a 12% SDS-PAGE gel and stained with
Coomassie (panel B). The starting material (HS; 1 pmol PDE) was included on the gel to
show the total proteins run over the column.
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binds to PDE. Thus, by this method alone, it is difficult to discern what proteins are
bound to PDE. However, comparisons o f this method with others such as
immunoprecipitation o f PDE, and western analysis of known ROS proteins would allow
for the identification o f some o f the proteins on the Coomassie-stained gel. Although y is
associated with PaP during gel filtration chromatography, it cannot be detected under
these conditions.
These results show preliminary evidence for novel PDE binding proteins.
Releasing PDE from its membrane-associated state may retain some o f the protein
interactions that exist on the disk membrane. One hypothesis is that there is a complex o f
visual transduction proteins that associate to allow for the rapid response time o f visual
excitation. A protein complex may also facilitate regulation o f visual transduction during
bleaching and light adaptation. The PDE signaling complex may mirror the Drosophila
invertebrate phototransduction system, where a PDZ-containing InaD protein organizes
phototransduction components on the rhabdomeric membrane (Tsunoda et al., 1997;
Bahner et al., 2000; Tsunoda et al., 2001).

Several ROS proteins in addition to PDE bind to 8 in vitro. Chapter 3 o f this thesis
presents a detailed study o f the 5 protein in frog ROS. This project evolved from
previously published work done with bovine photoreceptor cells (Florio et al., 1996;
Cook et al., 2000; Cook et al., 2001) and from our interest in proteins binding to PDE.
The hypothesis that 6 may be involved in membrane binding o f numerous proteins in a
variety of cells led us to examine the possibility that there are other proteins in ROS that
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could be associating with this protein. Many proteins involved in signal transduction use
prenylation as a means to reduce signaling pathways to a 2-dimensional process by
binding the important proteins to membranes. The putative PDZ and prenyl binding
domains o f the 5 protein suggests a scaffolding role for 5 that brings various proteins
closer to one another in the cell. Figure 4.7 examines solubilized proteins from purified
frog ROS that can be precipitated by GST-5 bound to glutathione beads. For each o f the
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Figure 4.7. 5 binding proteins from various ROS extracts. A. Frog ROS homogenates
(19 pmol PDE) were incubated overnight with recombinant frog GST-5 (0.4 nmol 5).
The sample was centrifuged at 30 psi for 3 min in the Airfuge. GST-5 released PDE (6
pmol PDE) was incubated with 20 pi o f glutathione agarose beads for 1 hour at 4°. B.
and C.Hypotonically extracted PDE (H, 4 pmol) or CHAPS extracted PDE (C, 5 pmol)
were incubated with 20 pi o f glutathione-agarose beads with 1.5 nmol GST-5 bound for
1.5 hour at 4°. The samples from all three extractions were centrifuged 5 min at 12,000
rpm to remove unbound proteins in the supernatant (U). The beads were then washed
with 50 pi o f TMN buffer (W). Proteins that bound to the beads were eluted (P) with 10
mM reduced glutathione in 10 mM Tris (pH 8). The glutathione beads were heated in
Laemmli sample buffer to 80° to remove any residual proteins that were not released by
glutathione treatment (B).
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extraction methods, a portion o f the PDE exists bound to the GST-5 beads. A few other
bands could be bound to PDE or 5 in this experiment, such as the band at 60 kDa in the
hypotonic and CHAPS extracted samples. In the sample where the ROS membranes
were incubated with GST-5 overnight, two very interesting bands are bound to the beads
at —50 and 48 kDa. These are possibly proteins binding directly to 5 as they are not
found in the samples extracted with CHAPS or hypotonic buffer. This experiment has
several limitations that control the amount o f information we can obtain. One problem
consistently observed is the breakdown o f the GST from the GST-5. Thus any bands on
the Coomassie gel that are less than 43 kDa could be from GST-5 breakdown in the
sample, and not ROS proteins bound to the beads. Second, the interaction o f GST-5 with
the glutathione beads is not very strong, so a portion o f GST-5 is found in the unbound
samples and the remainder is eluted from the beads and found in the precipitated sample
on the Coomassie gel. Thus, if there are any proteins running around 43 kDa they would
be overshadowed by the GST-5 that is in the sample.
To overcome these limitations o f doing pull-down with glutathione-agarose, we
coupled purified bovine 5 to CNBr-activated Sepharose (See Methods). Figure 4.8
presents 5 binding proteins found in bovine ROS. For this experiment, three different
samples were incubated overnight with 5-beads. PDE is found to bind to 5 as expected.
It was verified by western analysis that PDE and y both exist bound to the 5-beads (data
not shown). The hypotonically extracted proteins show the highest number of proteins
precipitated with the 5-beads. Proteins at 50 kDa, 48 kDa, 40 kDa, and 10 kDa are
specifically bound to the 5-beads. It is important to note that the precipitated proteins
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may be directly binding to 5, or bound to protein that is itself bound to 8 (such as PDE).
Although CHAPS removed more o f the proteins from the membrane, the CHAPS
extracted sample shows less proteins precipitating with 8, possibly due to disruption of
protein-protein interactions by the detergent.

15'
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Figure 4.8. 8 binding proteins in bovine ROS extracts. Isotonic soluble proteins (0.59
pmol PDE), hypotonically extracted proteins (8.25 pmol PDE), and CHAPS extracted
proteins (11.3 pmol PDE) were incubated with 30 pi o f 5-beads overnight at 4° in the
presence o f 0.1% Triton X-100. The unfractionated sample (S) is shown for each
condition. Nonspecific binding was estimated by the addition o f 0.9 nmol bovine GST-5
to each sample prior to the incubation (8). The beads were precipitated by centrifugation
(5 min at 12,000 rpm). Unbound proteins were collected (U). The samples were washed
3 times with 50 pi o f wash buffer (see Methods). Proteins were eluted from the beads by
heating to 80° in 2* Laemmli sample buffer (B).

An important reason for examining the proteins other than PDE that are coprecipitating with 8 is the low level o f 5 in ROS compared to that o f PDE. Quantitative
analysis o f the 8 protein (presented in Chapter 3), shows that there is a large excess o f
PDE in the outer segment compared to 8. This suggests that PDE may not be the major
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target o f 8 in the outer segment o f the photoreceptor cell. It would be very difficult for 8
to regulate PDE at such low quantities. The other proteins that are pulled down with the
8 protein would be more likely to be the candidate for 8 action in vivo as they m ay exist
in similar quantities.
Some o f the protein bands stained here could be the same as those observed
bound to PDE after gel filtration chromatography (Figure 4.7). Specifically, both the 8precipitation reaction and the gel filtration showed several bands in the 37-50 kDa range
on the Coomassie gel. T a and TP are known to run in this range, and it would not be
unexpected to find some T a bound to PDE, as some Ta-GDP can bind to PDE, though
with a lower affinity than Ta-GTP (Gray-Keller et al., 1990; Kutuzov and Pfister, 1994).
At the same time the Ty subunit is bound to the photoreceptor cell disk membranes by a
famesyl group similar to P a. Previously published result suggest that Ty and Tp would
not be precipitated, as they are not released from the disk membranes with 8 (Cook et al.,
2001 ).

There is still work that needs to be done to identify the proteins binding to PDE or
the 8 protein in vivo. Western analysis o f the gel filtration and 8-precipitation samples
with antibodies to known ROS proteins will give more information about some o f the
protein bands found on the Coomassie gels. Other proteins can be purified from the
SDS-PAGE and sequenced by MS-fingerprinting. These results can be compared to
experiments that examine 8 binding proteins in retinal extracts. There m ay be a common
protein that has yet to be identified that serves as the primary 8 target in several cell
types.
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Conclusions
The results presented in this chapter represent pilot studies for future projects
related to rod PDE regulation by novel proteins, as well as preliminary experiments that
formed the foundation for the published work presented in Chapters 2 and 3.
The inability to extract all o f the PDE from ROS membranes, along with the
incomplete removal o f y from PDE by non-enzymatic methods both suggest a
heterogeneity in the PDE population in rod outer segments. Heterogeneity with respect
to post-translational modification of the y subunit was one avenue that was partially
explored in this chapter in our efforts to develop methods to enrich for y from complex
protein extracts o f rod outer segments. It is possible that a a or pp homodimers may exist
in addition to the a p catalytic dimer that is assumed to predominate, serving as a sub
population o f PDE that with different y-binding or membrane-binding properties. The
observation that the kcat o f activated PDE was not significantly different when catalytic
dimers were prepared by trypsin proteolysis o f the y subunit versus extraction o f y by
transducin activation and centrifugal fractionation demonstrated that the proteolytic
treatment did not create artificially high catalytic rates for cGMP hydrolysis.
The role o f the 17 kDa 5 protein remains unclear. The preliminary work in this
chapter provides a new approach to identifying proteins that bind to 6 in photoreceptor
cells. This is an important first step to understand the role 5 plays to potentially organize
proteins that bind to 5 in photoreceptor cells. The strategy o f immobilizing potential
PDE binding proteins to identify novel proteins that interact with PDE and its known
associated proteins m ay lead to characterization o f a multi-protein signaling complex on
the disk membrane where PDE is activated, inactivated and allosterically regulated.
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SUMMARY

The research presented here examined the regulation o f rod photoreceptor PDE
upon transducin activation. In order to observe the mechanisms o f PDE regulation, we
first had to characterize the basic properties o f transducin activation. W e found that
transducin activation o f frog rod PDE reached half the maximal activation rate o f the
catalytic dimer (PaP), prepared by trypsin proteolysis or by a nonenzymatic method o f y
extraction. The y subunit plays an important part in regulating visual excitation by
inhibiting PDE activity. The interaction o f y with PaP is correlated with cGMP binding
to the noncatalytic sites o f P aP , such that when cGMP is bound, y is more tightly
associated. Indeed, we found that the release o f cGMP from the noncatalytic cGMP
binding sites directly correlates with y release from Pap.
A result that we continually observed in our studies o f PDE regulation was a
heterogeneity in protein and ligand binding to PDE. First, upon transducin activation of
PDE, there was heterogeneity in the dissociation of cGMP from the noncatalytic binding
sites. The effect o f transducin activation at the noncatalytic sites could be overcome by
the addition o f excess y. However, heterogeneity also existed in the binding o f y to PaP,
as two distinct classes o f y binding sites were seen when titrating P aP with y in the
presence o f cGMP.
When transducin activation o f PDE is prolonged, such as during light adaptation,
additional regulatory mechanisms are believed to take place. One protein hypothesized
to be involved in PDE regulation during light adaptation is the 17 kDa 8 protein. We
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examined the role o f the 8 protein in regulating frog PDE. Biochemical experiments on
the effect o f 5 on frog PDE agreed with previously published results done on m ammalian
PDE, showing 5 releasing PDE from the membrane and decreasing the maximal
transducin activated rate o f PDE. However, quantitative analysis resulted in less than 0.1
mol 5 per mol PDE in frog and bovine retinas localized to ROS. Consistent with this
finding, increased purification o f ROS showed a decrease in the amount o f 8 compared to
the entire retina. This suggests that 8 binding to rod PDE may be an artifact resulting
from 8 entering the outer segment during the purification process. Previous
immunocytochemical experiments were done with a 8 antibody that was not shown to
identify the 17 kDa 8 protein on immunoblots. Due to the low levels o f 8 measured in
outer segments by immunoblot analysis, we chose to reexamine 8 localization in the
retina by immunocytochemistry. Preliminary evidence observed with the 8 antibody that
we developed resulted in localization o f 8 to several cells in the retina, but not to rod
outer segments.
These results suggest that the designation o f the 8 protein as a subunit o f PDE was
premature. Recently published work on RhoGDI (Nancy et al., 2002) suggests that 8
may be one o f a family o f proteins that is involved in the trafficking o f prenylated
proteins to distinct membranes, due to the sequence similarity of 8 and RhoGDI. The
small amount o f 8 in the rod outer segment suggests that PDE is not the central target for
8. Preliminary experiments using immobilized 8 protein show that several different
proteins in the rod outer segment are capable o f binding to 8, or alternatively, form a
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complex with a protein that does bind to 5. One hypothesized role for the 5 protein could
be to form a scaffold for a group on interacting proteins.
The highly specialized role o f photoreceptor cells presents a unique model system
where the majority o f the protein and membrane components are involved in the same
process. Numerous interactions o f the proteins in the rod outer segment are likely to
work in concert to regulate visual transduction. Understanding the details o f how the
visual transduction pathway is regulated will allow us to determine the cause o f diseases
leading to the loss o f vision. Using this information, drugs can be developed to combat
vision loss in patients suffering from these diseases, allowing them to maintain a more
independent and fulfilling life.
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